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1 Biomaterials
Severe injuries can damage human tissues beyond repair. Nevertheless, such an 
irreparable damage to the human body does not necessarily imply the functional loss 
or reduction of the quality of life. Tissue restoration can be achieved by the surgical 
installation of a medical device, like an artificial heart, orthopedic or dental implant, 
artificial blood vessel, catheter, etc. Medical devices are made of biomaterials, 
which are defined as “materials of natural or manmade origin that are used to direct, 
supplement, or replace the functions of living tissues [1].” 
2 Biomaterials-associated infections
Although the application of medical devices improves the patients’ quality of life, they 
are also associated with problems. For example, the biomaterials, as used for the 
manufacturing of the medical device, can attract microorganisms and represent a niche 
for infection, which can be a risk for their human application. Currently, biomaterials-
associated infections (BAI) comprise a substantial clinical incidence of infections. For 
instance, 95% of cases of urinary tract infections are catheter-related, 87% of cases 
of bloodstream infection originate from an indwelling vascular catheter, and 86% of 
cases of pneumonia are associated with mechanical ventilation [2]. The initiation of 
BAI is usually due to microbial adhesion to the used biomaterial [3]. Once adhesion 
has occurred, the subsequent microbial proliferation leads to the development of a 
biofilm, which is resistant to most therapeutic agents at achievable concentrations. 
Subsequently, device removal is then required to ensure eradication of infection or to 
avoid relapse.
3 Status of antibacterial strategies to combat BAI
BAI can result from the multifaceted interaction of bacterial, device, and host factors. 
Among them, the bacterial factors are probably the most important in the pathogenesis 
of device-associated infection, whereas device factors are the most amenable to 
modification with the objective of preventing infection. Clinically, antibiotics are most 
commonly chosen to be active against bacterial infections and antibiotic-releasing 
biomaterials have been developed to prevent infections [4]. However, the occurrence 
of resistance against antibiotics has evoked a lot of concerns since the incidence 
of antibiotic-resistant pathogens has increased dramatically [5]. Long-term local 
application of the antibiotics can contribute to an amplified rate of antibiotic resistance 
[6]. Unfortunately, the increase of antibiotic resistance surpasses the pace at which new 
antibiotics are developed [5]. Therefore, as an alternative, the use of antiseptics, which 
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are chemical substances that prevent the growth and development of microorganisms, 
has attracted a lot of attention due to their decreased tendency to develop resistance.
4  The use of silver to enhance the antibacterial 
properties of biomaterials
Among the various types of antiseptics, the use of silver has got significant research 
interest to prevent infections. Silver was used in ancient civilization for its purity and 
to make jewelry. There are also some early reports that silver was used to maintain 
the quality of stored water [7]. Pharmaceutical application of silver was first recognized 
with the use of silver nitrate in the early 1800s for the treatment of ulcers. Later, due 
to the discovery of penicillin and its potent antibacterial properties, the interest of 
using silver to combat infections decreased and completely disappeared around the 
second world war [8]. It was not until the 1960s that silver was reintroduced in the form 
of 0.5% silver nitrate solution to treat burn wounds [9]. At present, silver has reemerged 
as a viable option for infection treatment [10]. Silver can be applied in the form of silver 
compounds, e.g. silver nitrate and silver sulphadiazine or as silver nanoparticles [11]. 
It has been demonstrated that: (1) metallic silver only causes minimum damage to 
living organisms, and (2) the silver ions are the major biologically active species in the 
application of silver compounds and silver nanoparticles. The antimicrobial properties 
of silver ions are mainly attributed to its ability to interact with proteins and enzymes, 
block cellular respiration and electron transfer, intermingle with nucleic acid and 
induce reactive oxygen species production  [9]. 
Silver can be incorporated into or coated on polymers or metals by e.g. lyophilization 
[12,13], dip coating [14,15], electrospinning [16], layer-by-layer deposition [17] and additive 
manufacturing [18]. These techniques provide a great potential for the use of silver 
to enhance the antibacterial property of biomaterials. However, to the best of 
our knowledge, only several studies are available that evaluate the efficacy and 
biocompatibility of silver incorporated biomaterials in vivo, i.e. silver-incorporated 
dressings to treat burns [19,20], silver-coated mega-endoprostheses or pins [21,22], 
polyurethane-silver nanocomposites for the manufacturing of catheters [23], silver-
coated implants [14], and silver-coated Dacron vascular grafts [24]. The in vivo evaluation 
of the antibacterial efficacy of silver can only be done by using a valid and reliable 
experimental animal infection model. Currently, following initial in vitro bacteriological 
analysis, a subcutaneous infection model has been well established as a secondary 
test to evaluate antibacterial efficacy of a biomaterial [25]. The subcutaneous model 
involves the bacterial inoculation around an implanted biomaterial and provides 
overall information of the efficacy of antibacterial additives. However, a more dedicated 
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model for testing the antibacterial efficacy of the biomaterial is needed when used 
for a specific application, for example, percutaneous devices are implants made 
of a biomaterial that penetrates through the skin. Percutaneous implants are used 
amongst others as external fixator in complicated bone fractures and for the fixation 
of an ear as well as limb prosthesis. Percutaneous implants are associated with the 
occurrence of bacterial infections at the skin exit-site, which can result in failure of the 
device. However, despite the previous attempts to constructing a convincing infection 
model for percutaneous applications [26-30], such a model is still not available. 
5 The objective of this thesis
The aim of this thesis is to explore the efficacy of using silver to enhance the 
antibacterial properties of polymeric biomaterials. More specifically, this thesis aimed:
–  to evaluate the existing animal models for percutaneous device-related infection, 
with a specific focus on the inoculation of bacteria,
–  to incorporate silver nanoparticles into polymers and evaluate their potential as the 
membrane for guided tissue regeneration,
–  to exploit the silver nanoparticles incorporated polymeric membranes as 
antibacterial wound dressing, 
–  to explore the efficacy of silver incorporated membranes as antibacterial 
percutaneous pin sleeve, 
–  to develop 3D printed polycaprolactone scaffold loaded with silver and lidocaine to 
prevent bacterial infection as well as provide pain relief using a one-step technique.
As scientific approach for these (sub)aims, we addressed the following research 
questions:
1  Which animal models in literature are available to evaluate the antibacterial 
properties related to percutaneous devices (Chapter 2)?
2  Do silver incorporated membranes hold potential for application in guided tissue/ 
bone regeneration (Chapter 3)?
3  Possess silver incorporated membranes antibacterial properties and wound 
healing ability when used as wound dressing (Chapter 4)?
4  Can silver nanoparticles incorporated chitosan-based membranes effectively 
prevent infection as pin sleeves (Chapter 5)?
5  Can silver and lidocaine be loaded into materials by 3D printing technique to 
prevent bacterial infection as well as provide pain relief (Chapter 6)?
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1 Introduction
A percutaneous device is an object made from a synthetic material, which penetrates 
the skin through a surgically created defect [1]. Presently, percutaneous devices are 
widely used in clinical treatment, and applications include, amongst others, indwelling 
catheters, external fixators, electrical connection of sensors, vascular access devices, 
dental implants, auditory prostheses, and orthopaedic prostheses [2]. Although the 
application of percutaneous devices greatly improves the quality-of-life of patients, 
there are still considerable drawbacks. Specific problems, as reviewed previously [3], 
include marsupialization (i.e. the process of epidermal migration along a percutaneous 
implant resulting in the formation of an epidermis-lined pouch in which the implant 
rests), per-migration (the process by which epidermal cells migrate through the pores 
of a percutaneous implant, eventually filling the pores with epidermal maturation 
products), bacterial infection or abscess formation, avulsion (mechanical disruption of 
the tissue/implant interface), and extrusion (destruction of tissue-implant continuity 
with loss of the implant function). In particular, the occurrence of an infection with 
bacteria colonizing the percutaneous device is a prelude to marsupialization, per-
migration, and avulsion. Thus, infection is the most common reason for the final failure 
of a percutaneous device. Infection rates around percutaneous devices are rather 
high in comparison with other categories of permanently implanted devices such as 
prosthetic joint infections (<2%) [4]; with reported rates ranging from 5%–30% in bone-
anchored prostheses [5,6] to over 50% for external fixators [7,8]. 
To prevent infection of percutaneous devices, researchers have explored different 
strategies. First of all, proper surgical procedures, e.g. hand hygiene and aseptic 
techniques, and systemic antimicrobial prophylaxis are applied as a standard in clinics 
for last decades. Furthermore, studies have been concentrating on the development of 
a dynamic interface between the skin tissue and the percutaneous device, for example 
by using biomaterials, by modifying the implant shape, or by applying specific micro-
and nano-conformations on the surface [9-14]. For the evaluation of those strategies, 
animal models without bacterial inoculation were usually employed. However, more 
recently the local application of antibacterial materials or antibacterial drugs has 
attracted more and more attention in the field of percutaneous devices, to prevent 
the occurrence of infections [15-17]. The efficacy of this new generation of antibacterial- 
containing devices can only be verified when a reliable percutaneous device-related 
infection model exists. Previous attempts of constructing a reliable infection model 
have been conducted [15,17-20], but at present, the animal species, the strain of bacteria, 
amount and method of inoculation, and the methods for subsequent evaluation of the 
infection, are still quite variable. Therefore, the purpose of this review is to evaluate 
the existing animal models for percutaneous device-related infection, with a specific 
focus on the inoculation of bacteria. 
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2 Animal models with spontaneous infection 
Different animals have been used in studies related to percutaneous devices. First, 
it can be questioned whether a spontaneously occurring infection can reliably be 
constructed, i.e. without the intentional inoculation of bacteria. In Table 1, such 
spontaneous infection rates are listed, which are the results from the control groups or 
groups without any treatment.
Table 1 |  Spontaneous infection rates around percutaneous devices in different animal 
models, not employing the inoculation of bacteria  
Species Position Study duration Infection rate
Mice Dorsum 3 days -6 months 0%[21-25]
Rats Dorsum 3 days -9 weeks 0%[26-29], 3%[12]
Scalp 1-3 weeks 0%[9,30], 8%[31]
Rabbits Dorsum 3 weeks - 8 months 0%[32-35], 12.5%[36], 50%[37]
Tibia 3 - 8 months 0%[35,38,39], 7%[36]
Proximal tibia metaphysis 4 weeks 58%[40],75%[41], 90%[42]
Scalp 3 weeks - 8 months 0%[35,38,39]
Guinea pigs Tibia 3 - 7 weeks 0%[35,38]
Dorsum 3 - 7 weeks 0%[35,38]
Micro-pigs or 
pigs
Limbs 14 days 44%[43]
Dorsum 1 - 15 months 0%[44], 13%[45], 17%[46]
Dorsum 90 days 25%[47]
Dogs Dorsum 4 - 32weeks 33%[48]
Goats or sheep Abdominal wall 4 months 8%[49]
Dorsum 14 weeks 0%[50]
Tibia 3 weeks-9 weeks 0%[51,52], 20%[53]
Proximal tibia metaphysis 24 weeks 85%[54]
In general, it can be concluded that spontaneous infection rates are relatively low 
(<25%), and moreover, authors describe a significant variability. Despite this variability, 
it seems that the highest natural infection rate might be achieved in investigations 
regarding the proximal tibia metaphysis in rabbits and sheep. Further analysis showed 
that the reason behind such higher infection rate was likely due to biomechanical 
factors, i.e. a relatively high mobility of the skin/soft tissues at the proximal tibia 
metaphysis area [54]. Therefore, the infection rates would largely depend on chance, 
and this circumstance would substantially increase the variability of the experiment, 
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and thus result in the necessity of using much more animals to evaluate treatment 
efficacy. All in all, it is concluded that achieving a reliable natural infection around 
percutaneous devices is not yet obtainable in an animal model.
3 Animal models with bacterial inoculation
3.1 Infection rates of animal models with bacterial inoculation
A common alternative way to obtain a more reliable rate of infection is to inoculate 
bacteria into the surgical wound. Microorganisms, primarily bacteria are responsible 
for most device-related infections. Indeed, ample explorations have been conducted 
to study the performance of percutaneous devices after deliberate infection (Table 2). 
For most of the studies, the infection rate in the control groups was quite reliable and 
(close to) 100%, even despite the fact that the animal models varied in many aspects, 
e.g. animal species, implant position, inoculated bacteria, and time points. Different 
from the natural infection process, where infection occurs when the increasing bacterial 
load eventually is too high to be combatted by the immune system, the controlled 
infection from bacterial inoculation can precisely standardize some important 
variables such as host, type of implant, inoculated bacterium, inoculated load, wound 
size, and duration of infection. Therefore, the inoculation of bacteria is a very effective 
way of constructing and investigating an infection around a percutaneous device.
3.2 The function of inoculated bacteria
To achieve a reliable infection at the exit site of a percutaneous device, researchers 
need to identify the exact effects of different bacteria on the formation of such an 
infection. In 1999, Clasper et al. inoculated S. aureus in a sheep external fixator model 
and detected the microbes present in the contaminated area on day 7 and 14. They 
described that in addition to the applied S. aureus, nine other species of microbes were 
detectable in the superficial implant tract or medulla [67]. Oka et al. [57] and Gimeno et 
al. [17] confirmed this finding in rabbit and sheep models, respectively. Later, Williams 
et al. provided more evidence to corroborate those results in a rabbit model [59]. In 
their experiment, a certain strain of S. aureus was repeatedly inoculated from week 
2 and weekly thereafter. Finally, the collected samples were analysed to ascertain 
the bacteria strains existing in the infection. It was found that the present pathogens 
were not only S. aureus but also other bacteria strains; however, the ratio of different 
bacteria was not described. More interestingly, the sub-strain S. aureus detected at 
the end of the experiment was representative of the normal skin flora, rather than the 
applied sub-strain of bacteria [59]. 
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Table 2 |  Infection rates around percutaneous devices in different animal models, when 
making use of the inoculation of bacteria
Species Posi-
tion
Bacteria Bacteria dose 
in solution 
volume
The way of inoculation Inoculation 
time post- 
operation
Duration 
after ino-
culation
Infection 
rate (con-
trol group)
Mice[55] dorsum S. aureus, 
 coagulase- 
 negative 
 staphylococcus
-- Swabbed painted onto 
entry site three strokes in 
the same direction
Immediately, 
or 7 days
1, 3, 6, 
12, 24, 48 
hours
100%, but 
diminished 
with longer 
time
Rats[56] femur S. aureus ATCC 
25923
1×107 CFU in 
0.1ml
Placed into implant-skin 
interface
Immediately 14 days 76.70%
Rabbits[57] femur MRSA ATCC 43300 1×108 CFU in 
1ml
Placed into implant-skin 
interface
Immediately 7 days 100%
Rabbits[16] tibia S. aureus ATCC 
29213
3×106 CFU in 
1ml
Subcutaneously injected 
into the implant site
5 days 9 days 100%
Rabbits[15] tibia S. aureus ATCC 
25923
1×106 CFU in 
0.1mL
Placed into implant-skin 
interface
Immediately 1, 2, 4 
weeks
100%
Rabbits[58] tibia S. aureus ATCC 
49230
1×108 CFU in 
0.2-0.8ml
Placed into implant-skin 
interface
14 days and 
weekly after
24 weeks 100%
Rabbits[59] tibia S. aureus ATCC 
49230
1×108 CFU in 
0.2 ml
Placed into implant-skin 
interface
14 days and 
weekly after
<24 weeks 100%
Rabbits[60] dorsum S. aureus ATCC 
49230
1×108 CFU Placed into implant-skin 
interface
4 weeks and 
weekly after
10 week 100%
Rabbits, 
pigs[61]
dorsum S. aureus  or 
E.coli
6×105 CFU in 
0.6 ml
Swabbed paint in 5 cm2 
area surrounding the 
implant
> 10 days 48 month 0%
Micro- 
pigs[62]
dorsum S. aureus and  
P. aeruginosa
1 ml Swabbed paint in 1 cm2 
area surrounding the 
implant
5 weeks 24, 48, 72 
hours
0%
Goats[63] iliac 
crest
S. aureus ATCC 
25923
7.6×105 CFU 
in 1ml
Placed into implant-skin 
interface
Immediately 16 days 100%
Goats[64] tibia S. aureus ATCC 
29213
2.4×107 CFU in 
0.1 ml
Placed into implant-skin 
interface
Immediately 
(keep for 1h)
14 days 100%
Goats[65] tibia S. epidermidis 
HBH276
3×105 CFU in 
0.1ml
Placed into implant-skin 
interface
Immediately 21 days 88.90%
Goats[66] tibia S. aureus ATCC 
29213
3×104 CFU in 
0.03ml
Applied to the pin threads 
before final insertion
In operation 14 days 95.80%
Sheep[67] tibia S. aureus ATCC 
29213
2.5×l04 CFU in 
0.1ml
Placed into implant-skin 
interface
Immediately 7, 14 days 70% (day7); 
100% 
(day 14)
Sheep[68] tibia S. aureus ATCC 
29213
5×107 CFU in 
0.2 ml
Placed into implant-bone 
interface with/without 
suspension retention
Immediately 1 hour 77.8%; 0%
Sheep[17] tibia S. aureus ATCC 
6538
5.5×107 CFU in 
0.1 ml
Placed into implant-skin 
interface
Immediately 7 days 100%
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In contrast, Koseki et al. constructed an infection model on the femur of rats by bacterial 
contamination and found that the bacteria isolated from the purulence or drainage were 
of the same strain as was inoculated [56]. However, this discrepancy might be explained 
by the fact that the latter study used specific-pathogen-free (SPF) animals. 
Based on the overall consensus, the mechanism of percutaneous infection after bacterial 
inoculation may be as follows (Figure 1). First, a local infection is initialized by the 
inoculation of bacteria. Thereafter, the properties of the percutaneous device, the host 
immune response, and the bacteria present in the microenvironment, are determining 
the final formation of an infection. If the infection is successfully constructed, after a 
prolonged period of time the final composition of the pathogens present depends on the 
interaction of the inoculated bacteria and the commensal bacteria. 
 Figure 1 |  The function of bacterial inoculation in percutaneous infection. (A) The bacteria 
are inoculated into the interface between percutaneous device and tissues. (B) In 
a bacteria-free environment, the pathogen in the formed infection is originating 
from the inoculated bacteria. (C) When the bacteria are inoculated in an 
environment with commensal bacteria of the host, the infection is initiated by the 
inoculated bacteria, but over time are mixed or replaced with commensal bacteria.
4  The construction of an animal model with bacterial 
inoculation
As mentioned, the initial infection can be achieved by bacterial inoculation; however, 
the final infection formation can still be influenced by various factors, i.e. the host 
immune response, bacterial inoculation load, the properties of the percutaneous 
device, and the environment around percutaneous devices. A successful infection 
model can only result from a balance among those factors. In this section, a detailed 
discussion on percutaneous device design, animal species, and bacteria, is conducted 
to facilitate the construction of an animal model.
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4.1 Percutaneous device design
4.1.1 Anchor design of implant
The anchor design of percutaneous devices not only is a major consideration to keep 
them at the implant site, but also can prevent physical avulsion at the skin-implant 
interface, by transferring the mechanical forces from the percutaneous area to the 
deeper subdermal tissues [21,32]. Various anchoring configurations have been proposed, 
ranging relatively from simple to more complex structures (Figure 2). According to the 
tissue composition of the anchoring site, percutaneous animal models can be divided 
into two major groups, namely soft tissue-anchored and bone-anchored percutaneous 
models. Irrespective of the anchoring design of the implant, sharp corners are to be 
avoided, since they cause stress peaks in the skin when external forces are applied to 
the protruding component [69]. 
 Figure 2 | Common applied percutaneous devices in animal models
The most common design for soft-tissue anchored percutaneous implants is the 
flange shape, and less commonly rod, cuff, sheet, or irregular shapes [23,35,38,70]. The 
flange-shaped implant mainly includes a large subcutaneous part with a relatively 
small percutaneous pole, where the large subcutaneous part serves as a secure 
anchor to the soft tissue [32,35]. The rod-shaped implant can be anchored using 
surgical methods, e.g. the internal part is fixed in a tissue tunnel (leaving both ends 
of implants exposed in the air), or by suturing the inside part of devices directly to the 
adjacent skin to improve the stability [23,24]. Cuff-shaped implants are anchored by 
the supposed ingrowth of soft tissue into the porosity of the cuff, and are commonly 
used for the manufacturing of catheters, like the Tenckhoff catheters [43]. Sheet-
shaped implants are usually composed of soft materials (e.g. Dacron® velour), 
which can be easily sutured to the skin [71]. A limited number of irregularly shaped 
implants are also described in animal models. For instance, Chehroudi et al. used a 
U-shaped design and in his studies to the effect of implant surface topography on 
marsupialization [70].
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The most common anchoring designs used in bone anchored percutaneous animal 
models are either screw type (threaded) or cylindrical (rod-shaped without thread) 
[72]. Screw type produces excellent initial stability, whereas stability a cylindrical shape 
depends on an exact fit within the bone [73,74]. Regarding rod-shaped implants, Chou et 
al. used a cerclage wire to further stabilize the cylindrical implant [58]. 
4.1.2 Exposure of implant
As the name speaking for itself, a percutaneous device always consists one part 
extruding through the skin. A percutaneous device fails when the skin covers the 
whole implant. Swelling and skin mobility appear to contribute to overgrowth of the 
skin. The problem might be solved by increasing the length of the exposure part of 
percutaneous implants [58]. In a mice dorsum percutaneous study, porous poly 
(2-hydroxyethyl methacrylate) implants with 2.5 mm to 5 mm long exposure were used 
[22-25]. The failure rate of 2.5 mm long exposure was 8/28 due to the overgrowth of the 
skin, but no failure was reported with 5 mm long exposure [22, 23]. In another study, the 
implant is designed with an enlarged cap, where the diameter of the exposed part is 
larger than that of the soft tissue surrounded part. Although the length of the enlarged 
cap was as short as 3 mm, only 2/40 implants were found to fail due to the overgrowth 
of skin [74]. Moreover, in several catheter studies with exposed lengths of 5 mm to 30 
mm in different animals, no implants failed due to skin overgrowth [27,43,55,71]. From 
a histological perspective, the exposure of a percutaneous device is related to the 
proliferation and migration of epithelial cells. The rate of proliferation and migration 
varies among different animal species. In rabbits this rate was fastest with a speed 
of 2.0 mm/week; in dogs intermediate with a speed of 1.6 mm/week; and in goats 
slowest with a speed of 1.5 mm/week [71]. Given that, the exposure length of the 
implant is closely related to its final status and this should be carefully considered 
when designing an experimental animal study.
4.2 The selection of the animals
Infection models have been constructed in various animal species, such as mice, 
rats, rabbits, micro-pigs, pigs, goats and sheep. Among them, rabbits, goats, and 
sheep seem more commonly used compared to mice, rats, or pigs. This may be 
firstly attributed to the fact that most infection models consider bone-anchored 
percutaneous devices, and thus rabbits and sheep have a more favourable size of the 
bone for common surgical positions located at the tibia, femur, and iliac crest. From 
this perspective, it could be argued that also micro-pigs or pigs are suitable models. 
However, only limited studies are available considering those species [61,62]. Further 
studies are needed to prove whether certain species of pig are indeed suitable as an 
animal model in this field.
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Small rodents (mice, rats) are not widely used as percutaneous device-related 
infection models. Cooper et al. tried to create an infection around soft tissue-anchored 
percutaneous devices by inoculating bacteria in mice. The infection was successfully 
induced, but the intensity of the infection subdued during the implantation time [55]. 
More recently, a femoral infection in rats was explored by inoculating a relatively large 
dose (1 × 107 CFU) of S. aureus into the implant-tissue interface. Even under such harsh 
conditions, the infection rate in the control group only reached 76.7% [56].  It is difficult 
to construct a reliable infection in small rodents, and therefore small rodents can only 
be used for preliminary studies. To this end, device-related infection models in the 
larger animals are preferable and recommended. 
4.3 Bacteria inoculation
4.3.1 The selection of the bacterial strain
The major aim of animal studies is to investigate the mechanism of various diseases 
in human beings for the purpose of preventing and treating diseases. Therefore, 
common pathogens related to human diseases are preferentially considered in 
percutaneous animal models (Table 2). The pathogens reported most commonly 
around percutaneous devices are bacteria such as S. aureus, Staphylococcus 
epidermidis, Escherichia coli, Pseudomonas aeruginosa [6,7, 75-77]. Especially, the 
bacteria shared between human and animal hosts are preferred. The most commonly 
selected and important bacterium for animal studies, S. aureus, causes most device-
related infections in both humans and animals, such as rabbits and sheep [20]. Last but 
not least, the selection of bacterial strains is largely determined by the study purpose 
or to facilitate the identification. For example, studies on antibiotic resistance or 
biofilm formation usually require certain strains of S. aureus or Pseudomonas 
with specific characteristics. Moreover, to facilitate the detection of the inoculated 
bacterium, an S. aureus sub-strain, which has been genetically selected to be 
resistant to streptomycin, is often used [66]. 
Both laboratory strains, as well as swabs obtained directly from patients, can be 
employed as a resource of bacteria for inoculation. Still, most studies choose 
laboratory strains, e.g. S. aureus American type culture collection (ATCC) 29213, 
25923 and 6538. S. aureus ATCC 49230 was selected for several studies as well, 
as they originate from a patient with osteomyelitis [58-60]. Less commonly, E. coli, P. 
aeruginosa, and S. epidermidis are selected. It is noteworthy that the S. epidermidis is 
usually chosen due to its ability to form biofilms and close relationship with late-onset 
prosthesis-related infections, compared to S. aureus, which is associated with early-
onset infections [17]. Approximately 99.9% of the bacteria in nature are the inhabitant 
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of a biofilm, and biofilms can play a critical role in resistance to antibiotics by serving 
as a protective barrier [19,56,78-81]. 
4.3.2 The load of bacteria
In 1982, Werner Zimmerli et al. published a key paper on the effect of foreign materials 
on the formation of infections [77]. By inoculating different loads of S. aureus to 
subcutaneous tissue cages, 102 CFU of S. aureus strain Wood 46 was sufficient to cause 
95% infection, whereas 108 CFU did not produce any abscesses without tissue cages 
implantation. Thus, the existence of a foreign material can greatly facilitate occurrence 
of infections. A summary of the infection rates and inoculated loads used in literature 
is presented in Table 2. One study inoculated different loads of S. aureus (2.4×107 CFU 
vs. 3×104 CFU) to the skin-implant interface immediately after surgery in a goat tibia 
model, and then assessed the effect on day 14 post operation. Although the difference 
in inoculated bacterial loads was large, the discrepancy in infection rates was small 
(100% vs. 95.8%) [64,66].  In a rabbit model, a high load (1×108 CFU) of S. aureus was 
inoculated at the skin-implant interface on day 14 post operation and then weekly 
after resulting in 100% infection [58,59]. In contrast, a low load (2.5×104 CFU) of S. aureus 
inoculated in a sheep tibia model resulted in the occurrence of only 70% animals [58-
60,67]. Even though these experiments were done with different settings, e.g. animal 
species, inoculation methods, and experimental duration, it can be speculated that 
the infection rate is related to the load of bacterial inoculation. A proper load of 
bacteria is a balance between creating an infection and giving the chance of combating 
the infection by animal and the antibacterial materials.
As there seems to be no common consensus, for each study design the inclusion of 
a pilot experiment is recommended. Such a pilot can elucidate the optimal bacterial 
dosage, the inoculation method, the timing, and inoculation frequency, to create a 
persistent infection over the entire experimental period, without producing systemic 
bacterial sepsis [15]. 
Further, it should be emphasized that in a percutaneous animal model, by definition, 
the wound is always exposed to the surrounding environment, even with the protection 
of a wound dressing. Thus, a load of bacteria, besides the inoculated ones, are always 
present in the microenvironment around the wound sites. Therefore, attention should 
be paid to both the inoculated bacteria and the environmental bacteria by using 
techniques such as aseptic operation procedures.
chapter 2
32
4.3.3 Inoculation methods
An efficient bacterial inoculation method is a prerequisite for the success of a 
percutaneous infection model. There are two frequently used methods for inoculation 
(Figure 3): 1) direct injection into the implant sites, 2) colonizing bacteria on the 
implant in vitro before implantation [76]. 
 
Figure 3 |  Two common ways of bacterial inoculation. (A) The bacteria suspensions 
are inoculated into the interface between percutaneous device and tissue to 
construct an infection. (B) The percutaneous device is first immersed into a 
bacteria suspension to form a biofilm. Thereafter, the biofilm-covered device is 
implanted percutaneously into the tissue to develop an infection.
Directly injecting bacteria at the implant-skin interface has been validated to be 
efficient in forming and maintaining an infection in many animal models [15,17,57-60,63-
65,67]. Clasper et al. applied a pin tract infection in sheep and found that the bacteria 
could rapidly (within 1 hour) pass the implant-bone interface into the medullary canal 
despite the fact the pins were well-fixed into the bone [68]. Such bacterial spreading 
into the medullary canal might be caused by micro-fractures from the drilling process 
[82]. Alternatively, efforts have been made by not injecting but rather swabbing the 
bacteria around the implant. Yet, in both rabbit and pig models, infections failed to 
form using this swabbing method [61,62]. Evidently, an animal model is only successful 
when the infection is maintained around the percutaneous exit-site for at least 1 hour 
[64], which the swabbing method cannot guarantee. 
Unlike the method of injecting, the method of colonizing bacteria onto the implant 
in vitro is less common. However, it is undeniable that this is a promising method to 
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inoculate bacteria, as there is more resemblance to some clinical conditions since this 
is the only way that a biofilm can reliably be formed on the implant [19]. The efficacy 
of this method has been verified by applying bacteria to the implant threads before 
inserting the implant into the femur of goats, resulting in a 95.8% infection rate 
[66]. In addition, mature biofilms of S. aureus have been created on the surface of 
membranes using a modified biofilm reactor in vitro. This biofilm-covered membrane 
can be potentially used in future to study biofilm-related infection [19]. In conclusion, 
colonizing bacteria on a device on beforehand contributes to future animal models 
on the relation between biofilms and percutaneous device-related infections, and 
warrant further studies.
Besides the bacterial inoculation approach, the time point of inoculation is another 
critical factor. The currently selected time points are quite different (Table 2). In most 
studies, the bacteria have been added to the wounds during surgery, or immediately 
after surgery. Other investigators started the inoculation after a given period of wound 
healing, ranging widely from 5 days to 5 weeks after surgery [16,58,62]. Also, repeated 
infection is applied. For instance, one rabbit model describes inoculation of bacteria 
from week 2 to 10 on a weekly basis [58]. Apparently, a single injection mimics the 
situation as occurs during surgery, whereas repeated inoculation mimics the clinical 
situation of a post-operative infection. Finally, since multiple implants are frequently 
installed in one animal, care should be taken to prevent contamination of adjacent 
(control) implants [57]. 
4.4 Collection of samples
The reliable collection of the specimens at the end point of an animal study is a 
prerequisite for subsequent microbiological and histological detection. Any retrieval 
method should contain steps for sterilization of instruments and implant site, 
collection, and bacteria detachment [63]. During harvesting, great care should be 
taken to avoid cross-contamination. 
In some cases, the whole implant with its surrounding tissue are removed for evaluation. 
The entire explant including the percutaneous device is placed into sterile saline, 
minced, sonicated, and then homogenized by a vortex shaker at high speed [57,83]. This 
method is an efficient way for further bacterial counts, isolation, and identification [66,83].
However, as an infection usually develops from outside to inside, the development 
stage of the infection, e.g. only soft tissue involved or osteomyelitis in the case of bone-
anchored implants, are beneficial information for the treatment. For this purpose, 
more complicated retrieving methods are used as described below (Figure 4). 
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Figure 4 |  Methods of sample collection for microbiological detection. For soft tissue,  
there are several methods described like (A) incision exposure method,  
(B) needle fluid harvesting method, (C) punch harvesting method.  For hard 
tissue, commonly described methods include  (D) advancing the tip of the 
percutaneous device to expose sample site, (E) applying force to form transverse 
fracture to expose sample site, (F) resecting the lower part of the bone marrow 
cavity by reaming,  to expose the sample site.
For the identification of the infection in soft tissue, swabs from the tissue-implant 
interface are preferred to be collected. The most simple and popular method is to 
expose the tissue-implant interface by making incisions (Figure 4 A) [67]. Alternatively, 
the tissue-implant interface is accessed by using a biopsy punch from 5 mm distal to 
the skin/implant interface to take out a sub-dermal tissue for swabs (Figure 4 B) [18,59]. 
These two methods are quite applicable for post-mortem animals. For the live animals, 
the samples can be harvested several times by a needle without termination of the 
experiment (Figure 4 C) [62]. Here, 1 ml of sterile saline is directly injected from distal 
skin to the tissue adjacent to the implant, after 1 min, 0.1 ml of liquid is withdrawn for 
subsequent microbiological detection. 
Likewise, to identify infection in bones, there are also several methods to expose bone-
implant interface or bone marrow surrounding the implant. Advancing tip method is 
relatively straightforward. The implant is pushed through the bone to show the tip 
for further examination (Figure 4 D) [84].  Alternatively, the whole bone-interface can 
be exposed by creating a transverse fracture in the same plane of the implant (Figure 
3 E) [67]. Moreover, the entire medullary canal can be opened by aseptically resecting 
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the lower half of the bone to show the bone marrow surrounding the implant (Figure 
4 F) [18,59]. Such an approach maximally avoids contamination from exposure operation, 
and thus gives a very reliable result of medullar status; however, it is particularly 
applicable to very thick bones.
4.5 Evaluation of infection
There are three main methods to detect and qualitatively or quantitatively evaluate 
infection, i.e. (1) to score clinical signs of infection, (2) to apply a microbiological 
detection, and/or (3) to perform a histological assessment. 
4.5.1 Clinical signs of infection
To score clinical signs associated with infection is the most popular way to evaluate the 
infection status. Upon visual inspection, grading is employed. Most widely adopted is 
the guideline for clinical signs of infection in accordance with the study of Checketts et 
al.[85]. This grading scale is defined as follows:
–  Grade I level of infection: slight redness of skin with slight discharge around the 
implant, with one or more of the following symptoms: appetite suppression, limited 
water consumption, lethargy, distress/ limping, and/or pain and tenderness at the 
implant site.
–  Grade II level: redness of skin, discharge from the implant site, and pain and 
tenderness on palpation of the soft tissues. 
It is noteworthy that the grade II is not only regarded as a sign of infection but also 
widely accepted as a standard ‘humane endpoint’ to avoid the excessive suffering of 
animals [17,59,60]. 
4.5.2 Microbiological detection
A variety of standard microbiological procedures can be used for classification 
(qualitative culture) or measurements (quantitative counting) of the present strains 
of bacteria. Bacterial culture is the most common method to screen and quantify 
bacteria. Moreover, matrix-assisted laser desorption/ionization-time of flight mass 
spectrometry (MALDI-TOF MS) can be applied as an accurate and rapid technique 
to identify bacteria [86]. Furthermore, pulsed field gel electrophoresis is applied to 
identify bacteria [59]. Besides, there is another emphasis on using a morphologically 
recognizable or certain antibiotics-resistant bacteria to facilitate the identification of 
bacteria or on applying more advanced genotyping techniques [66]. 
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As biofilms are currently attracting increased attention in the infection study, it is 
worthwhile to mention that the interactions of biofilms with materials can be detected 
with imaging techniques. Confocal microscopy, electron microscopy, single particle 
tracking microscopy and fluorescent correlation spectroscopy are all possible 
techniques to elucidate these interactions [65,87-90]. 
4.5.3 Histology/ histomorphometry
In histology routine, gram staining is the most commonly selected method to detect 
the presence of bacteria [19,91]. Although histology does not guarantee 100% accuracy, 
it is still described to be the most reliable tool for detection in animal models [58]. The 
scoring of only clinical parameters of infection can be misleading, as not all infections 
show obvious clinical symptoms [67,68]. Also, using only microbiological detection is 
not always reliable due to the relatively low culture sensitivity of bacteriological swabs 
[76]. Therefore, it is recommended that the occurrence of the infection is determined 
by at least two positives among clinical signs of infection, microbiological cultures, 
and histology [16,58,59,66]. Moreover, to facilitate the statistical analysis, the parameters 
above should preferentially be assessed in a quantitative way [92,93]. A well-designed 
quantification method, avoiding the excessive influence of any single parameter, could 
contribute to the comparison among study groups, or the relation to other studies.
5 Conclusions and future perspectives
Infections related to the use of percutaneous devices remain a prevalent complication 
in many clinical applications. This comprehensive review of all currently available 
animal models evidences that there is still no accepted animal model to study 
percutaneous device-related infections. Still, overall it seems that the models that 
apply standardized inoculation of laboratory bacterial strains are more reliable and 
repeatable than models in which spontaneous infection has to occur. Regarding the 
animal species, large animals seem to be more reliable. Even though the inoculated 
bacteria strains vary, the standard laboratory strains are preferred as they are more 
easily available and more reproducible. Moreover, a pilot study is recommended to 
elucidate the optimal bacterial dosage, the inoculation method, the timing, and the 
inoculation frequency. To obtain reliable results, aseptic surgical procedures should 
be strictly followed. The various sample collection methods are dependent on the 
specific application, and all are well-described regarding applicability and reliability. 
It is advisable that conclusions are always drawn from positive signs based on at 
least two detection methods of clinical symptoms, microbiological detection, and/or 
histology. A major challenge for the future is to design acceptable animal models in 
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which all aspects are standardized and specialized for certain areas of research, such 
as catheter-related infections and pin tract infections. Moreover, further emphasis 
should be placed on models which regard biofilm formation on percutaneous devices. 
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1 Introduction
Periodontitis is a chronic inflammatory disease of the tooth supportive tissues [1]. It 
begins as an infection caused by the microflora of the dental plaque that forms adjacent 
to the teeth. With dental plaque developing, the number of gram-negative anaerobic 
bacteria (i.e. mainly Porphyromonas gingivalis (Pg) and Fusobacterium nucleatum (Fn)) 
increases [2,3]. The subsequent inflammation leads to the destruction of periodontal 
tissues as well as alveolar bone and can eventually result in tooth loss. Periodontitis 
is highly prevalent, e.g. from 2009 to 2012, 46% of US adults representing 64.7 million 
people had periodontitis, with 8.9% having severe destructive periodontitis [4]. 
The treatment of destructive periodontitis involves surgical intervention, including flap 
surgery, bone grafting as well as guided tissue regeneration (GTR) [5]. The strategy of 
GTR is to isolate the periodontal defect from the faster-growing connective tissue using 
an occlusive membrane so that the slower-growing periodontal tissues can occupy 
the defect area [6,7]. From a clinical point of view, the GTR membranes must function 
for at least 4 to 6 weeks to allow the periodontal tissues to regenerate [8,9]. However, 
during this time period the GTR membranes face the risk of bacterial colonization 
when exposed to the bacteria-rich oral cavity, e.g. via soft tissue dehiscence [10]. 
Therefore, the development of a GTR membrane that combines structural integrity 
with antibacterial properties is of great importance to improve the success rate of the 
GTR procedure.
Various biomaterials have been investigated for GTR application. Among them, 
chitosan, a naturally derived biopolymer, seems to be quite suitable due to its excellent 
biological performance, i.e. non-toxicity, biodegradability, and inherent antibacterial 
properties [11,12]. To meet clinical requirements, the antibacterial property of chitosan-
based materials is commonly enhanced with addition of antimicrobial agents [13,14]. 
However, the incorporation of classical antibiotics risks development of bacterial 
resistance [15]. On the contrary, agents, like silver, have a much lower tendency to 
induce bacterial resistance [16,17]. Especially the use of silver nanoparticles (AgNPs) is 
promising, as AgNPs have 1.4 – 1.9 times stronger antibacterial properties compared to 
silver ions [18]. Nevertheless, AgNPs have been observed to induce toxicity (to mammal 
cells) at elevated concentrations [19], although AgNPs are reported to be non-toxic in 
most studies [20]. 
In our previous study, we developed AgNPs incorporated into electrospun chitosan-
based membranes, which facilitated a sustained release of silver for at least 28 
days [21]. Therefore, this study aimed to explore the biological performance of 
these membranes, in terms of antibacterial effect, in vitro cytotoxicity, and in vivo 
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biocompatibility. To this end, three groups of membranes with different amount of 
AgNPs were tested for antibacterial properties against Pg and Fn for up to 28 days. 
The cytotoxic effect of the membranes was explored by culturing human periodontal 
ligament cells (PDLCs). Finally, the tissue response of the membranes was evaluated in 
vivo by subcutaneous implantation in rabbits. 
2 Materials and methods
2.1 Material preparation
Chitosan (degree of deacetylation = 90%, molecular weight = 200-400 kDa, Heppe 
Medical Chitosan, HMC+, Halle, Germany), poly (ethylene oxide) (PEO, Molecular 
weight = 900 kDa, Sigma-Aldrich Chemie GmbH, Steinheim, Germany), glutaric 
dialdehyde (GA, 25 wt. % solution in water, Merck KGaA, Darmstadt, Germany), acetic 
acid (99.9%, Boom BV, Meppel, Netherlands), and silver nitrate (AgNO
3
, Sigma-Aldrich) 
were used as received. Ultrapure water was made by Milli-Q system (Millipore, Merck). 
Table 1 |  The composition of electrospinning solutions 
Sample Ag0 Ag1 Ag5
Chitosan (g) 0.72 0.72 0.72
PEO (g) 0.48 0.48 0.48
AgNO3 (µg) 0 12 60
Total polymer:AgNO3 100:0 100:1 100:5
35% Acetic acid (mL) 40 40 40
Three solutions were prepared for electrospinning and named as AgX (X = 0, 1 or 5) 
based on the AgNO
3
: polymer ratio as shown in Table 1. The electrospinning setup was 
the same as previously described [21]. In brief, solutions were stirred overnight to ensure 
complete dissolution of the polymers and silver salts. The solutions were loaded into 
a 10 mL syringe (BD Plastipak; Becton Dickinson S.A., Madrid, Spain). A Teflon tube 
(Eriks B.V., Alkmaar, Netherlands) was connected to the syringe and an 18 G spinneret. 
A syringe pump ((KD Scientific, Inc., Holliston, MA) was used to control the flow rate 
at 4 mL/h, and the distance between the spinneret and collector was set to 18.5 cm. 
The electrospinning voltage was set to 28 – 30 kV. After electrospinning, the obtained 
membranes were cross-linked in GA vapor for 2h as described previously [21], and then 
left in a fume hood overnight to remove solvent residuals. The membranes were cut into 
discs (12 mm in diameter) for all the in vitro tests and square membranes (15 mm × 15 
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mm) for the in vivo study. All the samples were sterilized by γ-radiation at a dose of 25 
kGy (Synergy Health Logistics B.V., Ede, Netherlands) before the further experiment.
2.2 Morphology characterization
The morphology of the electrospun fibrous membrane was observed by field emission 
scanning electron microscopy (SEM; Sigma 300, Zeiss, Zeiss, Oberkochen, Germany). 
The fiber diameters were measured at 100 random locations from 5 different images 
using Image J (National Institutes of Health, Bethesda, MD) [22]. The formation and 
distribution of AgNPs in the electrospun fibers were evaluated by transmission 
electron microscopy (TEM; JEOL 1010, Tokyo, Japan).
2.3 Antibacterial test
The disk samples (12 mm in diameter, ~ 2.0 mg in weight) were first incubated in 1mL 
phosphate buffer saline (PBS, Gibco, Paisley, UK) and agitated gently at 37°C. The PBS 
was refreshed every 2 to 3 days.  On day 0, 7, and 28 the disk samples were lyophilized 
for further usage. The antibacterial properties were evaluated against two typical 
periodontal pathogenic bacteria, i.e. Pg (ATCC 33277) and Fn (ATCC 25586) using a 
disk diffusion test or modified Kirby-Bauer test [23,24]. In brief, aliquots of 3 × 108 CFU of 
Pg or Fn in physiological saline were spread evenly over the entire surface of Brucella 
agar plate (Becton Dickinson, Franklin Lakes, NJ). Lyophilized disk samples described 
above (n = 3) were placed on the Brucella agar plate with penicillin and metronidazole 
tablets as positive controls. All agar plates were transferred into GasPak jars (Becton 
Dickinson). An anaerobic environment with 0.2% O
2
, 9.9% CO
2
, 5% H
2
 and 84.9% N2 
was achieved by Anoxomat Mark II (Mart Microbiology B. V., Drachten, Netherlands). 
The zone of inhibition was measured after incubation of 48 h for Fn and 72 h for Pg at 
36 °C.
2.4 Cell viability
Silver and membrane cytotoxicity was tested using human periodontal ligament 
cells (PDLCs) [25-27]. All experiments were done by following national guidelines for 
working with human materials (Dutch Federation of Biomedical Scientific Societies, 
human tissue and medical research: code of conduct for responsible use. Available at 
http://www.federa.org/). PDLCs were harvested from an extracted third molar from 
a healthy adult patient (18 years, female). The cell culture medium was Dulbecco’s 
Modified Eagle Medium (DMEM; Gibco, Paisley, UK) supplemented with 10% fetal calf 
serum (FBS; Sigma-Aldrich) and 100 U/mL penicillin/streptomycin (Gibco). The cells 
were cultured in culture medium under a CO
2
 (5%) atmosphere at 37 °C for 3 passages 
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and then frozen in liquid nitrogen in DMEM containing 20% FBS and 10% dimethyl 
sulfoxide (DMSO, Sigma-Aldrich) until use. After thawing, cells were expanded until 
passage 6, and then seeded on 24 well culture plates or coverslips (Thermanox Nunc, 
Naperville, IL) at a density of 5×104 cells per well for 24 h before the assays.  
To determine the cytotoxic effect of AgNO
3
, the culture medium was replaced with 1 
mL of culture medium containing a series of AgNO
3
 ranging from 0 – 100 µg/mL (n = 
3). Fresh culture medium and 5% DMSO in culture medium were used as positive and 
negative controls, respectively. 
To assess the cytotoxic effect of AgNPs incorporated membranes, membranes 
weighing 0.5, 1.0, and 2.0 mg from each group (resulting in Ag1 with 5, 10, 20 µg AgNO
3
, 
and Ag5 with 25, 50, 100 µg AgNO
3
 in the membranes, respectively) were placed in 
trans-wells with 0.4 µm pores (Greiner Bio-One GmbH, Frickenhausen, Germany), 
and then transferred to the cell culture wells with 1 mL fresh culture medium. The 
experiment was performed in triplicate.
After 20 h, the culture medium, for both the AgNO
3
 samples and the AgNPs 
incorporated membrane samples, was replaced with 1 mL culture medium containing 
10% Alamar Blue dye (Bio-Rad, Hercules, CA). After 4 h of incubation, a 200 µl aliquot 
of metabolized medium from each well was transferred into a 96-well plate (Greiner 
Bio-One) in duplicate and the absorbance was measured at 570 nm and 600 nm in a 
Synergy HTX multi-mode reader (BioTek Instruments, Winooski, VT). 
For the Live/Dead assay, samples on coverslips (n = 2) were exposed to calcein AM/ 
ethidium homodimer-1/PBS working solution (Invitrogen, Carlsbad, CA) for 30 min at 
37 °C according to the manufacturer’s instruction, and then observed at wavelength 
of 488nm for live cells (green) and 568 nm for dead cells (red) by an automated 
fluorescent microscope (Axio Imager Microscope Z1; Zeiss).
2.5 In vivo implantation
For the in vivo evaluation, based on the antibacterial and cytotoxic test results and 
following the 3R rules (replacement, reduction, and refinement) of animal experiments, 
only Ag0 and Ag5 membranes (measuring 15 mm ‐ 15 mm, ~ 5.5 mg) were compared. 
The protocol was approved by the Institutional Animal Care and Use Committee of 
Innoheart (2015/022), Singapore. Fourteen 12-month-old male New Zealand white 
rabbits (Oryctolagus cuniculus), each weighing 3 – 4 kg, were used. The dorsum was 
chosen as implant location. The procedure included subcutaneous implantation of 
membranes alone or membranes contained in a tissue cage (Figure 1). The tissue cages 
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were made of stainless steel 304 meshes with the size of 1.5 cm in length and 0.8 cm in 
diameter and were prepared as described previously [28]. All the samples were labeled 
by one investigator and were implanted and analyzed blindly by the other investigators 
to avoid bias. 
  
 
 
Figure 1 |  Implantation scheme for in vivo evaluation.  (A) Five subcutaneous pockets were 
made per rabbit. The anterior sites (1, 2) were selected to implant membranes alone, 
and the posterior sites (3, 4, 5) were adopted to implant membranes contained in 
tissue cage and empty tissue cage as sham control. (B) Photograph of the implants. 
From top to bottom, a piece of electrospun membrane (15 mm × 15 mm), an empty 
tissue cage, and a membrane-containing cage. Scale in cm with mm subdivisions.
The rabbits were anesthetized with isoflurane, and their backs were shaved and 
disinfected with alcohol and iodine scrub. Five 2 cm long incisions per rabbit were 
made on the dorsum skin and subcutaneous connective tissues were blunt dissected 
(Figure 1). The membranes (Ag0 and Ag5) were randomly distributed to the two anterior 
pockets, and three tissue cages, of which two maintained membranes (Ag0 and Ag5) 
and one was an empty tissue cage as sham control, were randomly distributed to the 
three posterior pockets according to numbers generated from https://www.random.
org/. After implant insertion, the skin was closed with 4-0 absorbable VICRYL® 
sutures. The wound healing status and post-operative condition were recorded every 
week. After 4 and 12 weeks, 7 rabbits were euthanized by an overdose of Nembutal. 
After shaving and disinfection of the skin with 70% ethanol, a central incision was 
created to expose the subcutaneous tissues.
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The anterior specimens with surrounding tissues were retrieved, labeled, fixed 
in 10% phosphate-buffered formalin for 48 h, and stored in 70% ethanol. Then, the 
specimens were dehydrated in a graded series of ethanol and embedded in paraffin, 
after which 5µm sections from at least three arbitrary regions were cut perpendicular 
to the long axis of the tissue capsule using a standard microtome (Leica RM 2165, Leica 
Microsystems, Nussloch, Germany). The sections were stained with hematoxylin and 
eosin (H&E) for general evaluation, elastica van Gieson (EVG) for measurement of 
the thickness of the fibrous tissue capsule, and tartrate-resistant acid phosphatase 
(TRAP) for observation of macrophages and foreign body giant cells (FBGCs). The 
thickness of the fibrous tissue capsule surrounding the anterior specimens (Figure 
2) was measured at 6 evenly distributed points per histological section and for three 
sections of each sample.
 
Figure 2 |  The thickness of capsule (shown in pink) is measured perpendicular to the 
surface in EVG staining as indicated by the arrow. Scale bar: 100 µm. 
For the posterior samples, the exudates inside the tissue cage implants were collected 
using 25 gauge needles. The collected exudates were centrifuged at 240 g at 4 °C for 
10 min to precipitate cell pellets. All the cell pellets from the same group were pooled 
together for RNA extraction prior to PCR array analysis. Due to blood contamination 
in the 4-week samples, only the samples collected at week 12 were tested. Rabbit 
inflammatory cytokines and receptors RT2 profiler PCR array (QIAGEN Inc., Valencia, 
CA) was conducted to profile the expression of 84 key genes mediating the 
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inflammatory response. The relative fold change of gene expression between groups 
was calculated and then showed in a heat map using a web tool: http://biit.cs.ut.ee/
clustvis/. A fold change of more than 4 was arbitrarily regarded as significant.
2.6 Statistical analysis
All data were reported as mean ± standard deviation, and were analyzed using one-
way analysis of variance followed by Tukey’s multiple comparison test (for more than 
two groups) or t test (for two groups) by Graphpad Prism 5.0 (GraphPad Software Inc., 
San Diego, CA). Differences were considered statistically significant at p < 0.05 or less.
3 Results
3.1 Morphological characterization
The electrospun membranes showed a uniform fibrous structure (Figure 3). The 
average fiber diameter was approximately 175 nm, and the addition of AgNO
3
 in the 
electrospinning solution had no significant effect on the fiber diameter.
 
 
Figure 3 |  Scanning electron micrographs and fiber diameter distributions of Ag0 (A, B), 
Ag1 (C, D), and Ag5 (E, F), with average size of  177 ± 60 nm, 185 ± 58 nm, and  
168 ± 58 nm, respectively. Scale bar: 1 µm.
The distribution of AgNPs in the fibers was assessed by TEM (Figure 4). Homogenous 
electro-dense areas, which indicated the formation of AgNPs, was detected in the Ag1 
and Ag5 groups, while there was no sign of electron dense areas in the fibers of the 
Ag0 group. 
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Figure 4 |  Transmission electron micrographs of nanofibers. (A) Ag0, (B) Ag1, (C) Ag5. The 
dark dots in the fibers indicate the presence of AgNPs. Scale bar: 100 nm.
3.2 Antibacterial test
The long-term antibacterial effect of the membranes was evaluated against the typical 
oral pathogenic gram-negative anaerobic bacteria Pg and Fn (Figure 5). Ag0 specimens 
showed no inhibition zone and the bacteria grew under the membranes. Ag1 and Ag5 
displayed an obvious inhibition zone around the membranes against both Pg and Fn 
even after 28-day immersion in PBS. Further quantification showed that Ag5 exhibited 
a significantly larger inhibition zone than Ag1. 
 
Figure 5 |  Zone of inhibition test against Porphyromonas gingivalis (Pg) and Fusobacterium 
nucleatum (Fn). The membranes were pre-immersed for 0, 7, and 28 days in PBS. 
The optical photos of membranes are shown in the left panel. The corresponding 
diameters of inhibition zone in the right panel, with dot lines indicating the 
original diameter of the discs (12 mm). # indicates no inhibition zone. * indicates  
p < 0.05, and ** p < 0.01.
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Figure 6 |  Cell viability assays. (A) Cell viability after directly culturing in DMEM containing 
0 – 100 µg/mL AgNO
3
; (B) Cell viability after trans-well-cultured with 0 – 2 mg 
membranes; Fluorescent images of cells after trans-well-cultured with  
(C) 2mg-Ag0; (D) 2mg-Ag5. Live cells were stained as green by calcein AM; dead 
cells should be stained as red by ethidium homodimer-1, and no dead cells were 
detected. Scale bar: 200 µm.
3.3 Cell viability
Cell viability in culture medium containing different amounts of AgNO
3
 is shown 
in Figure 6A. An AgNO
3
 concentration below 3 µg/mL in DMEM medium showed no 
cytotoxicity, and the concentrations of AgNO
3
 showing 50% reduction in cell viability 
(IC50 = half maximal inhibitory concentration values) was 5µg/ml. 
The cytotoxicity of AgNPs incorporated membranes are displayed in Figure 6B-D. 
Figure 6B illustrates the PDLC viability in the presence of membranes. No cytotoxicity 
could be observed for all the samples, including the group of 2.0 mg Ag5 membranes, 
corresponding to 100 µg total AgNO
3
 incorporation. The results of the fluorescent Live/
Dead staining (Figure 6C-6D) confirmed that all the cells were viable with the presence 
of membranes (green color) and no dead cells (red color) could be found. 
chapter 3
58
3.4 Descriptive histology of host tissue response
After surgery, all animals remained in a good health condition and showed no sign 
of wound complications including infection or adverse tissue response (i.e. redness, 
swelling). At retrieval, all specimens (direct or cage implantation) were found to be 
surrounded by a tissue capsule, without indication of serious inflammation or pus 
formation. 
Figure 7 |  Histology (H&E staining) of explanted tissues. The left images are the overview 
of the capsule, and the right images are the corresponding magnified local 
view. m: membranes, i: area infiltrated with inflammatory cells, f: fibrous tissue 
capsule. Scale bar in left images: 1000 µm, in right images:  100 µm.
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Representative HE stained images are depicted in Figure 7. All implanted membranes 
did stain red and were found to be intact after both 4- and 12-week implantation. The 
membranes did not show any visual signs of degradation. The tissue response from 
4 and 12 week samples showed a similar histological appearance. All membranes 
were folded-up into a wave-like structure and surrounded by a tissue capsule, which 
was featured by the presence of connective tissue and inflammatory cells (mainly 
leucocytes). The inflammatory cells mostly aggregated in the vicinity of the membrane, 
which was displayed in a dark purple color. Over the implantation time period, 
the capsule thickness appeared to decrease, while the presence of inflammatory 
cells appeared unchanged. Higher magnification indicated that the membranes 
had a layered structure, and the marginal area of the membranes were in a loose 
structure with cells infiltration; however, no cells had infiltrated into the center of the 
membranes. EVG staining revealed that no significant differences existed in capsule 
thickness between Ag0 and Ag5 after either 4 or 12 weeks of implantation. However, 
the fibrous capsule after 12 weeks of implantation was significantly thinner compared 
to those after 4-weeks implantation (Figure 8).
 
 
 
Figure 8 |  Quantification of the thickness of the fibrous tissue capsules after 4 and 12 
weeks of implantation. Significance: * indicates p < 0.05, ** indicates p < 0.01.
TRAP staining of the light microscopic sections (Figure 9) indicated the infiltration of 
macrophages into the various materials and FBGC formation. Macrophages and FBGCs 
were stained red and were observed to be mainly located in an interfacial area between 
the membrane and the surrounding fibrous capsule. No differences in appearance 
could be detected between Ag0 and Ag5 samples after both 4 weeks and 12 weeks of 
implantation.
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Figure 9 |  Histology (TRAP staining) of the explanted samples. The red spots indicated by 
small black arrows are the macrophages or the foreign body giant cells. Scale 
bar: left image 1000 µm, right image 100 µm.
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Figure 10 |  Gene expression analysis in the in vivo study. The fold change of detected 
inflammatory cytokines are shown after 12 weeks. The empty cage was used as 
control. A significant up-regulation of gene expression is labeled red, and down-
regulation blue.
3.5 Expression of inflammatory cytokines/chemokines
Gene expression for the inflammatory cytokines/chemokines of exudates from 
explanted 12-week tissue cage samples were assessed. The results of 19 out of the 
84 tested cytokines/chemokines were discarded because their average threshold 
cycles were higher than 30, meaning the gene expression was too low to be detected 
accurately. The relative fold change of gene expression for the remaining 65 cytokines/
chemokines are shown in Figure 10. In general, compared to the sham control, both Ag0 
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and Ag5 showed high inflammatory profiles as demonstrated by the overexpression of 
inflammatory cytokines/chemokines (higher than 4-fold). Specifically, the cytokines/
chemokines related to the presence of macrophages, e.g. CCL4, CCR1, CCR5, CSF1, 
CX3CR1, were all significantly up-regulated. Also IL10, a common cytokine to inhibit 
inflammation, was significantly up-regulated, whereas the cytokines to promote 
inflammation, IL17A and IL18, were not significantly changed. When Ag5 and Ag0 were 
compared, there were no significant changes in gene expression for the majority of the 
cytokines, except for IL6 and CCL4. For Ag5, the expression of IL6, a pro-inflammatory 
cytokine, was down-regulated compared to Ag0, whereas CCL4, a pro-inflammatory 
chemokine attracting monocytes and other immune cells, was up-regulated. 
4 Discussion
In the current study, we aimed to evaluate the biological performance of chitosan-
based membranes, which contained silver nanoparticles. Our hypothesis was that 
AgNPs: (1) would enhance the antibacterial properties of the membranes, and (2) 
had no adverse effect on the soft tissue to the membranes. Our main findings showed 
that the incorporation of AgNPs in the chitosan-based membranes produced a dose-
dependent antibacterial effect against Pg and Fn for at least 28 days. The chitosan 
based membranes were not cytotoxic in vitro and the silver incorporation did not affect 
the evoked in vivo tissue response.
With many bacteria developing resistance to conventional antibiotics, silver is widely 
used for disinfection by functioning in forms of silver ions or AgNPs. AgNPs were 
widely explored mostly because they can act as the depot to continuously release 
silver ions, and the released silver ions are commonly accepted as the biochemically 
active agent [29]. In the antibacterial process, the positively charged silver ions destroy 
the negatively charged bacterial membranes and lead to damage of the bacterial 
respiratory chain enzymes as well as their DNA. Eventually, this mutual effect induces 
bacterial death through cell lysis and leakage [30]. In our previous studies, AgNPs 
incorporated electrospun membranes resulted in a sustained release of silver for 
a period of 28 days [21]. Besides, the TEM images of the cross-section of membranes 
showed that the AgNPs almost disappeared after 28-day immersion [21]. In agreement 
with the release study, the current study demonstrated that the persistent antibacterial 
property of AgNPs-GTR membranes against Pg and Fn lasted also for at least 28 days, 
with Ag5 showing a stronger antibacterial effect than Ag1. This long-term antibacterial 
effect is consistent with the sustained release of silver ions. The stronger effect of Ag5 
over Ag1, indicates that the antibacterial properties of the membranes can be adjusted 
by controlling the silver concentration.
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Although the antibacterial property of silver is evident, the cytotoxicity of silver 
nanoparticles is a major concern for its clinical application. Cytotoxicity of AgNPs 
may be considered from two aspects, i.e. silver ions by dissolution of AgNPs and the 
“Trojan horse” effect of AgNPs. The silver ions have been explosively accepted as 
having a dose-dependent toxicity. In a study by Vrcek [31], the toxicity of silver ions was 
determined. It was shown that silver ions displayed a dose-dependent cytotoxicity to 
the human hepatoblastoma (HepG2) cells, and the IC50 value of silver ions was 0.5 µg/
mL. In the current study, the IC50 of silver ions was found to be 5 µg/mL to PDLCs. Here, 
PDLCs showed a higher cytotoxic threshold compared to HepG2 cells, this discrepancy 
may indicate that different cell types or different experimental setups may induce a 
different cytotoxic threshold to silver agents. One the other hand, the membranes 
containing AgNPs showed no obvious cytotoxicity to the PDLCs. This suggests that 
the silver ions released from the membranes did not reach the cytotoxicity threshold 
in this study.  The other most widely spread theory is the “Trojan horse” mechanism 
of biocidal activity of AgNPs [32,33]. In that theory, AgNPs could act as a Trojan horse 
to enter the cells, release silver ions in the cytosol and consequently induce cellular 
apoptosis. To understand the cytotoxicity mechanism of the AgNP-incorporated 
membrane, it would be ideal to distinguish the form of the released silver, i.e. particles 
or ions. However, the current analytical tools have difficulties to achieve this goal 
[34,35]. It deserves more research efforts in future to distinguish AgNPs and silver ions. 
Clinically, the membranes for biomedical application must not interfere with the tissue 
healing response, which is characterized by a mild inflammatory response, followed 
by fibroblast proliferation, granulation tissue formation, and tissue remodeling [36]. 
In literature, only a few reports are available dealing with the subcutaneous tissue 
response to silver-containing materials. Zhang et al. [37] evaluated implanted nAg–
HA–TiO2/PA66 membranes and e-PTFE membranes in a rat subcutaneous model 
for 1, 4 and 8 weeks and found that the membranes were surrounded by granulation 
tissue. The granulation tissue layer was thicker for the e-PTFE group at 1 and 4 weeks 
than for the silver composite group. However, the thickness of the granulation tissue 
decreased to a thin layer for both composite group and e-PTFE group at 8 weeks. 
Similarly, Takamiya et al. [38] implanted subcutaneously polyethylene tubes filled with 
a pure fibrin sponge or a fibrin sponge loaded with various types of silver nanoparticles 
for 7, 15, 30, and 90 days. It was observed that the different groups showed a similar 
inflammatory response at all experimental periods, i.e. the formation of granulation 
tissue and a fibrous capsule. In the current study, the main aim was to evaluate whether 
the incorporation of AgNPs would have an effect on the tissue response. Therefore, we 
only included the chitosan based membranes without AgNPs as a control/reference 
material, and the Ag5 membrane with the strongest antibacterial efficacy in vitro. To 
reduce the number of experimental animals, Ag1 membrane was not included in the in 
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vivo study. The subcutaneous implantation of membranes alone in the rabbits caused 
a fibrous capsule formation, which became thinner from 4 to 12 weeks for both groups. 
Besides, the distribution of macrophages and FBGCs were similar between groups. 
Nevertheless, when critically regarding the thickness of the fibrous tissue capsules, 
all chitosan based membranes induced a relatively thick capsule. As reported from 
our previous study [39], this relatively thick capsule may be due to the mismatch of the 
mechanical property between implanted membranes and the surrounding tissues. 
The fact that the membranes were folded up due to capsule contraction indicates that 
the membranes were lacking capacity to remain a stable shape. The folding up of the 
membranes might have resulted in an increase of inflammatory cells at the interface 
of membranes and tissues; and indeed, the macrophages and FBGCs were mostly 
distributed in these areas. Still, our main question could be answered positively as 
the incorporation of AgNPs did not result in a larger capsule thickness. Therefore, we 
can still conclude that the incorporation of AgNPs does not have an effect on tissue 
response.
The current study further analyzed the effect of the incorporation of AgNPs on in vivo 
cytokine gene expression profiles. For this purpose, tissue cages were implanted 
that were either empty or containing membranes with or without silver. All the cages 
containing membranes showed a significantly up-regulated gene expression of 
most cytokines, especially the cytokines related to macrophages, likely as a normal 
foreign body response which occurs to any implanted biomaterial. However, there 
was no significant alteration in the gene expression of most detected cytokines for 
the membranes with vs. without the silver. Still, two cytokines, i.e. IL6 and CCL4, were 
changed significantly in gene expression as a result of the AgNPs. The expression of 
IL6, commonly identified as a pro-inflammatory cytokine [40], was significantly down-
regulated. However, the expression of CCL4, the other pro-inflammatory chemokine 
that attracts activated T cells, monocytes/macrophages, NK cells, and eosinophils 
[41], was significantly up-regulated. Together, the results from the PCR array were 
inconclusive regarding the effect of silver on inflammatory status. 
Furthermore, for biomedical applications, such as GTR, the membranes should stay 
intact for at least 4 to 6 weeks to allow the periodontal tissues to regenerate [8,9]. In 
this study, although the loose structure of marginal area of the membranes showed 
some cells infiltration, the middle part of the membranes stayed intact and without 
cell infiltration even after 12-weeks of implantation. This appears to be a promising 
characteristic of the membranes and can support the formation of a physical barrier 
to stop the ingrowth of unwanted cells. This absence of degradation may be due to 
the cross-linking treatment of the chitosan based membrane and the relatively high 
degree of deacetylation of chitosan. i.e. 90% [42]. 
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Despite the benefits of AgNPs, special concerns should be raised to their safety for 
biomedical applications. The most common effect of the chronic exposure is permanent 
bluish gray discoloration of the skin (argyria) or the eyes (argyrosis) [43]. Fortunately, this 
adverse effect rarely happen and has mostly been reported after the intake of a large 
amount of AgNPs [35,43-45]. Furthermore, the exposure to silver compounds may produce 
toxic effects to organs like liver and kidney and to respiratory system and circulation 
system [43]. Nevertheless, pre-treatment of AgNPs, such as washing or coating, has 
been reported to be able to lower the toxicity to a safe level for skin application [46]. In 
this study, the incorporation of AgNPs in the polymers could be another efficient way to 
lower their cytotoxicity both in vitro and in vivo. 
5 Conclusion
This study shows that the incorporation of silver nanoparticles can provide a sustained 
antibacterial assistance to chitosan-based membranes in a dose-dependent manner. 
Further in vitro cell culture revealed that the incorporated amount of AgNPs did 
not cause a noticeable cytotoxic effect on periodontal ligament cells. The in vivo 
study demonstrated that the incorporation of silver nanoparticles into the chitosan 
based membranes did not alter their soft tissue response. This warrants the further 
investigation to their usefulness in biomedical field, such as GTR procedures.  
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1 Introduction
Silver has been widely explored to enhance the antibacterial property of medical 
devices, such as wound dressings, catheters, and external fixators [1-3]. In topical burn 
treatment, silver sulfadiazine (SSD)  is even regarded as the gold standard [1]. Silver 
can be applied in the form of silver salts, e.g. silver nitrate and silver sulphadiazine, 
or as silver nanoparticles (AgNPs) [2]. Compared to silver salts, AgNPs have a 
prolonged release of silver and this feature contributes to the reduced frequency of 
dressing changes, and thus the reduction of pain caused by dressing changes and the 
associated costs [4].
However, the toxicity of AgNPs is still under debate. Several studies postulate that 
AgNPs can be more toxic towards bacteria than towards mammalian cells, leading to 
a therapeutic window that can kill bacteria without harm to mammalian cells [5,6]. In 
contrast, other studies have reported AgNPs had the same cytotoxic threshold towards 
bacteria and human cells [7]. This discrepancy might lie in the used culture medium for 
assessing toxicity. Most studies assess antibacterial effects in culture medium without 
serum, which is known to interact with nanoparticles [8]. Furthermore, the inorganic 
ions in body fluid might also interact with AgNPs [9], but their effects on silver release 
are often overlooked. 
Wound dressings, one of the medical products often with AgNPs incorporation, are 
designed to remove exudates, to inhibit invasion of exogenous microorganisms, and 
improve skin appearance [10]. For wound dressings, it is critical to evaluate the relevant 
property of a biomaterial in a more clinically relevant condition. Interestingly, despite 
the large amounts of studies on AgNPs related materials, there are only limited studies 
available about the antibacterial evaluation of AgNPs in vivo and those studies are 
mostly evaluating the antibacterial property indirectly through the wound healing rate 
[11,12]. Furthermore, there is no consensus among the studies about the effect of silver-
containing dressings on wound healing, as evidenced by reports about delayed [13,14], 
accelerated [1,10,15-17], and no changed wound healing rate [18,19]. 
In this study, we therefore aimed to elucidate first the mechanism of proteins and 
inorganic ions on the silver release from the AgNPs incorporated chitosan-based 
membranes in vitro, to explore their antibacterial efficacy both in vitro and in vivo 
and the wound healing ability in vivo. To this end, we first conducted a silver release 
study in phosphate buffered saline (PBS) to reflect the ionic microenvironment and 
in fetal bovine serum (FBS) to further elucidate the influence of proteins. After that, 
we evaluated the antibacterial property of membranes after immersion using the 
zone of inhibition against Staphylococcus aureus. A rat subcutaneous intra-operative 
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contamination model was selected to further test antibacterial efficacy in vivo. Finally, 
the wound healing ability was evaluated using a rat excisional wound splinting model.
2 Materials and methods
2.1 Material preparation
The samples were fabricated using an electrospinning technique. Briefly, 40 ml 
electrospinning solutions containing 26ml ultrapure water (Millipore Corp, Bedford, 
MA, USA), 14 ml acetic acid (99.9%, Boom BV, Netherlands), 0.72 g chitosan (degree 
of deacetylation = 90%, molecular weight = 200-400 kDa, Heppe Medical Chitosan), 
0.48 g polyethylene oxide (PEO, Molecular weight = 900 kDa, Sigma-Aldrich®) with 
0 (Ag0 group), 12 mg (Ag1 group), or 60 mg (Ag5 group) silver nitrate (AgNO
3
, Sigma-
Aldrich®) were stirred overnight. The solutions were electrospun to membranes at a 
flow speed of 4 ml/h, a distance of 18.5cm between collecting plate and spinneret, and 
a voltage of 28-30 kV. The membranes were crosslinked with glutaric dialdehyde (25 
wt. % solution in water, ACROS Organics™) vapor at room temperature for 2 hours. 
After the cross-linked membranes were dried, they were cut into 12 mm-diameter disks 
for further study. All the disk samples were sterilized by 25 kGy γ-radiation (Synergy 
Health, Ede, The Netherlands).
2.2 Morphology characterization
The morphology was observed by field emission scanning electron microscopy (SEM; 
Zeiss Sigma 300, Germany) with X-ray energy-dispersive spectrometry (EDS; Bruker, 
Billerica, MA). All samples were sputter-coated with a thin layer of chromium before 
the detection. The fiber diameters were measured at 100 random locations from 5 
different images using Image J (National Institutes of Health, Bethesda, USA) [20]. The 
distribution of AgNPs was detected by JEOL 1010 transmission electron microscope 
(TEM; JEOL, Tokyo, Japan).
2.3 Silver release behavior in different biological solutions
The disk membrane of 4 mg from each group (n = 5) was placed into 1.5 ml Eppendorf® 
tubes containing either 1 ml phosphate buffer saline (PBS, Gibco™) or fetal bovine 
serum (FBS, Sigma F7524, Taukirchen, Germany). The tubes were incubated at 37 °C 
with gentle agitation. At each predetermined time point, 900 µl superna on day 0, 4, 
7, 11 and 14 after surgery on day 0, 4, 7, 11 and 14 after surgery tant was collected for 
further analysis and then refreshed with 900 µl PBS or FBS correspondingly. The silver 
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concentration in the collected supernatants was determined by using inductively 
coupled plasma mass spectroscopy (ICP-MS X series I, Thermo Scientific, Waltham, 
MA). The collected supernatant was diluted 20× with 1% nitric acid before the ICP-MS 
analysis. A standard calibration curve was prepared with silver concentrations ranging 
from 8 to 1000 ng/ml. Furthermore, to further elucidate the alteration of PBS and FBS 
immersed samples, 2 extra samples were retrieved at each predetermined timepoint 
and lyophilized for SEM-EDS detection.
2.4 In vitro antibacterial test
The disk samples were incubated in 1 ml of PBS with gentle agitation at 37°C. PBS 
was refreshed every 2 to 3 days on day 0, 4, 7, 14, 21, and 28, the disk samples were 
lyophilized for further evaluation (n = 3). A zone of inhibition test (modified Kirby–Bauer 
test) was adopted to evaluate the antibacterial property against typical pathogenic 
bacteria in skin wound, Staphylococcus aureus (S. aureus ATCC® 25923™, Manassas, 
USA) [21]. Standard tablets containing 30 µg of cefoxitin were used as the positive 
control. In brief, the bacterial suspension was prepared by mixing the S. aureus ATCC 
25923 strain with sterile saline (0.85% w/v NaCl in water) to McFarland Standard value 
of 0.5 and further diluted for 10 times. The bacterial suspension was smeared evenly on 
Mueller Hinton agar plate (BDTM, Becton Dickinson, Franklin Lakes, NJ). Then the disk 
samples were placed in the center of agar plates, using a different agar plate for each 
disk sample. After inoculation for 20 hours at 36 °C, the diameters of the transparent 
zones of inhibition were measured. 
2.5 In vivo evaluation
The animal study was approved by the Animal Experiments Commission of Radboud 
University and the national Central Animal Experiments Committee (CCD No. AVD10300 
2015-241) according to the legal regulations as stipulated in the amended Animal 
Testing Act in the Netherlands and Directive 2010/63/EU of the European Parliament 
and of the Council. 
Blinding and randomization were applied throughout the animal study. All the samples 
in the animal experiments were labelled and the group information were kept by an 
independent investigator, who did not participate the following surgery, histological 
and microbiological detection until all the data were collected. Randomization was 
achieved using a computerized random sequence generator (www.random.org).
The animals were housed under standard conditions and received food and water ad 
libitum. All animals were acclimatized for two weeks before the surgery. All surgery 
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was conducted by inhalation of 5% (isoflurane/oxygen) and maintained by inhalation 
of 2.5% (isoflurane/oxygen). After surgery, Buprenorphine (Temgesic®, Reckitt 
Benckiser, Slough, United Kingdom) and carprofen (Rimadyl®, Pfizer, New York 
City, NY) were subcutaneously injected for analgesia immediately and also on day 1 
postoperatively. 
2.5.1 In vivo antibacterial test
42 male specific-pathogen-free (SPF) Charles river Wistar Hannover [CRL: WI (Han)] 
rats (weight 250– 300g) were randomly assigned to 3 study groups with 2 sacrifice 
time points, i.e. day 7 and day 28. After anesthesia, the hair on the back of the rats 
was shaved. Two 1.5 cm-long linear incisions were created bilaterally on rat dorsum. 
Disk samples were placed into the pockets. Following implantation, 50 µL bacterial 
suspension containing 1×106 CFU of S. aureus in PBS were immediately inoculated into 
the pocket directly above the implant. The incisions were then closed with staples. 
After 7 or 28 days, the rats were euthanized by inhalation of a mix of CO
2
 and O
2
. The 
capsulated samples, i.e. tissue capsules and embedded disk samples, were collected. 
The collected samples on the right dorsum were used for enumeration of bacteria, and 
those on the left dorsum were treated by histology. 
For microbiological detection, the capsulated samples were incised to separate the 
implanted disk samples from the surrounding tissues, and the bacterial amount on 
the disk samples and the tissue samples were counted separately. The samples were 
then cut to small pieces, added into 1 ml of 0.85% saline, vortexed for 30 seconds, 
ultrasonically treated for 5 mins, and vortexed again for 30 seconds to isolate the 
bacteria from the tissues or the membranes [22]. The bacterial suspensions were 
then diluted in serious of 10 times and quantified by bacterial counting method with 
countable colonies of 10-200 per agar plate after inoculated on Columbia Blood Agar 
with 5% Sheep Blood plates (CBP, BD™), Columbia CNA Agar with 5% Sheep Blood 
plates (CNA, BD™), and MacConkey Agar without Salt plates (MCP, BD™). The CBP is 
rich agar plate to culture all the bacteria in the suspension, CNA is used to selectively 
culture gram-positive cocci (streptococcus/ staphylococcus), and MCP is selected to 
culture gram-negative rods like E. coli. Based on the colony morphology, the bacterial 
colonies were identified primarily by smearing the bacteria in 2 drops of physiological 
saline or rabbit plasma, where S. aureus was dispersed in saline (-), but clustered 
in plasma (+). For suspicious colonies, matrix-assisted laser desorption/ionization 
with time-of-flight mass spectrometer (MALDI-TOF, Billerica, MA) was further applied 
to identify the bacteria. After the bacterial counting, the silver content in the tissue 
samples was evaluated by ICP-MS.
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After retrieval, the collected samples on the left dorsum were fixed in 4% buffered 
formaldehyde for 48 hours, immersed in 70% ethanol for at least 2 days, then dehydrated 
in series of ethanol, and embedded in paraffin. Thereafter, 5 µm-thick sections were cut 
using a Leica RM 2165 Microtome (Leica Biosystems, Wetzlar, Germany). For each sample, 
sections from 6 sequences of parallel layers of samples were collected and stained with 
routine hematoxylin and eosin (H&E) staining and Brown-Brenn modified Gram staining. 
For H&E staining, paraffin sections were deparaffinized in xylene, rehydrated to water, 
stained with a Delafield hematoxylin, dehydrated again to 96% ethanol, and stained with 
Eosin. For Gram staining, paraffin sections were deparaffinized in xylene, rehydrated 
to 96% ethanol, treated with ammonium ethanol, rinse in water, stained with filtered 
Hucker-Conn solution, rinsed with water again, treated with Lugol, rinsed in water and 
dried, treated with 60°C acetate acid ethanol, rinsed with water, and stained with Twort 
solution. After staining, the sections were sequentially rinsed in ethanol and xylene, and 
mounted with DPX (BDH Laboratory Supplies, Dorset, UK).
2.5.2 In vivo wound healing evaluation
An excisional wound splinting rat model was selected to prevent wound closure 
caused by skin contraction in order to heal the wounds through granulation and re-
epithelialization [23]. 16 male SPF CRL: WI (Han) rats (weight 250– 300g) were assigned 
to 4 balanced Latin square for 4 groups, i.e. sham control, Ag0, Ag1, and Ag5 group. The 
donut-shaped splints (Inner Ø12 mm, Outer Ø 22 mm) were punched from red silicone 
sheets (JTR-SA-1.0-Silicone Isolator Sheet Material, 0.9 mm Thick, Grace Bio-Labs, 
Bend, OR). Then, the splints were sequentially ultrasonically washed in 10% liquinox 
detergent (Alconox, New York, NY, USA), isopropanol and ultrapure water (Millipore) 
for 2 min, respectively. Before surgery, the splints were autoclaved at 121°C for 15 min. 
The surgical procedure is performed as described [24,25]. In brief, after anesthesia, 
4 of 8 mm-diameter circular wounds were punched bilaterally on the dorsum with 
disposable biopsy punches (Integra™ Miltex®, Plainsboro, NJ). The splints were 
glued and sutured to the surrounding skin by 4-0 suture (Coated VICRYL®, Ethicon 
Inc., Somerville, NJ). The disk samples were placed to cover the whole wounds, and 
further stabilized with transparent film dressing (3M™ Tegaderm™, St. Paul, MN). 
Subsequently, the dressings were secured with bandages (Petflex® No-Chew Cohesive 
Pet Bandages, Portsmouth, NH) by wrapping to the front part of the fore leg to prevent 
damage from paw movement or chewing. The samples were changed and standardized 
digital wound photographs were taken with a ruler as calibrator on days 0, 4, 7, 11, and 
14 with the bandages being reapplied. The animals were euthanized on day 4 and 14 by 
inhalation of a mix of CO
2
 and O
2
. The wounds with the surrounding skins were retrieved 
for histological and histomorphometrical analysis.
chapter 4
78
The wounds reduction was quantified with a method adapted from a previous 
publication [24]. After the image scale was calibrated with the ruler on each photograph, 
the wounds areas were measured. Then wound reduction was expressed as % original 
wound area using the following equation:
% original wound area = wound area at day 0  × 100%
The paraffin sections were prepared using the same method as described in 2.5.1. In 
addition to routine HE staining, the collagen was stained with Elastine van Gieson (EvG) 
staining, neovascularization was assessed by α-smooth muscle actin (αSMA) staining, 
and macrophages and foreign body giant cells (FBGCs) were identifed by ED1 staining. 
For EvG staining, the paraffin sections were dehydrated with xylene, rehydrated to 96% 
ethanol, stained with Lawson solution, rinsed in 96% ethanol, stained the nuclear with 
Weigert A + B, rinsed in water, and stained with van Gieson’s picrofuchsin. For αSMA 
staining, the sections were treated with 3% H
2
O
2
 in methanol to inactivate endogenous 
peroxidase, and post-fixed with 4% formaldehyde in PBS. After rinsing with 0.075% 
glycine in PBS (PBSG), the sections were incubated in citrate buffer (pH 6.0) at 70°C 
for 10 min followed by incubation with 0.075% trypsin in PBS at 37°C for 5 min for 
antigen retrieval. The sections were pre-incubated with 10% normal donkey serum 
(NDS, Chemicon, USA) followed by overnight incubation of 1st antibody mouse-anti-rat 
αSMA (1:51200; Serotec, DPC, the Netherlands) at 4 °C. Subsequently, the sections 
were incubated with secondary antibody donkey-anti-mouse IgG (1:750; Jackson Labs, 
USA) for 60 min in dark, treated with avidin biotin complex(ABC) for 45 min in dark, and 
treated with 3,3-diaminobenzidine (DAB) until dark brown staining. Until now, PBSG 
was always used to rinse the sections between the treatments. Then the sections 
were rinsed in water, and the staining was intensified with 0.5 CuSO
4
 in 0.9% NaCl. 
After rinsing with water, the sections were counterstained with Delafield hematoxylin. 
After staining, the sections were dehydrated sequentially with ethanol and xylene 
and mounted with DPX (BDH Laboratory Supplies). For ED1 staining, the procedure 
is like αSMA staining. There were only two differences. First, the antigen retrieval was 
achieved by incubation in 0.075% trypsin in PBS at 37°C for 15 min. Second, the first 
antibody was mouse-anti-rat ED1 (1:500; Serotec, DPC, the Netherlands). 
 
wound area at day X
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Figure 1 |  The quantification by using macros of image J. (A) (D) and (G) The typical images 
from EvG, αSMA, and ED1 staining.(B) (E) and (H) The region of interest after 
threshold using macros. (C) (F) and (I) The amplified local area after threshold.
All slides were digitized with the same parameter using a 3DHistech Panoramic 250 
Flash II scanner (3DHistech, Budapest, Hungary). After exporting the images, the 
complete wound area was selected as the region of interest (ROI) by hand. The ROIs 
were then quantified with macros created by image J as shown in Figure 1. The collagen 
formation, vessel density, and macrophage density were calculated by using the 
following formulas.
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% collagen=total area of region of interest  ×100%
vessel density=total area of region of interest
macrophage density=total area of region of interest
 
2.6 Statistical analysis
All data were reported as mean ± standard deviation and were analyzed using one-way 
analysis of variance followed by Tukey’s multiple comparison tests or Kruskal-Wallis test 
followed by Dunn’s multiple comparisons test by GraphPad Prism 5.0 (GraphPad Software 
Inc., San Diego, USA). Differences were considered statistically significant at p < 0.05.
3 Results
3.1  Morphological characterization of AgNPs incorporated 
membranes
The fibrous membranes with different amounts of AgNPs were fabricated by 
electrospinning, and their morphologies were characterized by SEM and TEM. SEM 
images (Figure 2A-C) showed a uniform fibrous structure for all groups with a similar 
average fiber diameter of ~ 200 nm (P > 0.05). TEM image (Figure 2D) demonstrated 
that the electron-dense AgNPs were formed within the fibers. 
3.2 In vitro interaction with biological solutions 
After immersion, the PBS did not alter the thickness of the membranes but the FBS 
resulted in an obvious increase of the thickness by visual observation. Figure 3A 
showed the morphological changes after immersion in PBS or FBS. The membranes 
kept their fibrous structure after immersion in PBS, while more and more white spots 
appeared on the fibers with the increase of silver amount and immersion time. Further 
identification using EDS revealed that the white spots had a high amount of silver 
and chloride. For the FBS-immersed membranes, a thick layer of protein was clearly 
observed on the fibrous membranes since day 4.
EDS identification (Figure 3B) demonstrated that silver was detectable on the surface 
of membranes throughout the test period after PBS immersion whereas no silver was 
present on the surface after FBS immersion except for the Ag5 membrane after 28-day 
immersion.
collagen area (B)
macrophage number (H)
vessel number (E)
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Figure 2 |  The SEM images of the electrospun membranes of (A) Ag0, (B) Ag1, and (C) Ag5 
groups. (D) the TEM image of single fiber from Ag5 group, where the electron-
dense areas were silver nanoparticles.
The released silver from the chitosan-based membranes in either PBS or FBS was 
quantified by ICP-MS as shown in Figure 3C. The PBS immersed groups resulted in a 
slow but sustained silver release manner and that the amount of released silver was 
independent on the amount of AgNPs incorporated in the membranes. By contrast, 
the FBS immersed groups showed a fast silver release of up to 1 day and 7 days for Ag1 
group and Ag5 group, respectively. Afterward, no more released silver was detectable. 
The cumulative release percentage relative to the theoretical amount of silver in each 
membrane was successfully fitted by an allometric power growth equation y = ktn 
(Table 1).
Table 1 |  Cumulative release (%) of silver from chitosan membranes and the parameters 
obtained from curve fitting using Korsmeyer-Peppas model (y = ktn). 
PBS-Ag1 PBS-Ag5 FBS-Ag1 FBS-Ag5*
Burst release (within 6 h) 1.18 ± 0.16 0.27 ± 0.01 34.76 ± 5.45 3.4 ± 0.57
Total release (after 28 days) 10.49 ± 0.51 2.16 ± 0.01 46.30 ± 5.82 23.53 ± 1.75
k 0.027 0.006 N.A. 0.105
n 0.40 0.38 N.A. 0.61
Adjusted R2 0.99 0.99 N.A. 0.95
*  Based on the release data during day 0 to day 4; N.A. means not applicable due to not enough data 
points.
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Figure 3 |  In vitro interaction with PBS and FBS.( A) The SEM micro-images of membranes 
after immersed in PBS and FBS. Scale bar: 1µm. (B) The percentage of silver in 
the immersed membranes as quantified by EDS. (C) The silver release profile of 
the membranes.
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3.3  In vitro antibacterial efficacy after interaction with biological 
solutions
The antibacterial property of membranes after immersion in PBS and FBS was 
quantified by a zone of inhibition (ZOI) test (Figure 4). All the Ag0 membranes did not 
have any ZOI as expected. After immersion in PBS for up to 28 days, both Ag5 and Ag1 
groups showed ZOI and the diameter of ZOI was decreasing with increased immersion 
time. On the contrary, the FBS immersed membranes revealed that the Ag5 membranes 
had a ZOI only until day 4 and  Ag1 membranes did not show a ZOI. 
 Figure 4 |  The diameter of zone of inhibition of the membranes against S. aureus. The 
dashed line indicates the sample diameter. Data are shown as mean ± SD.
3.4 In vivo antibacterial efficacy
The antibacterial properties of the membranes were evaluated both microbiologically 
and histologically after 7-day and 28-day subcutaneous implantation challenged by 
S. aureus intra-operatively. The membranes were encapsulated by fibrous capsules, 
and the samples were collected as membranes and tissue capsules separately. The 
bacterial identification through MALDI-TOF confirmed that all the bacteria in the 
samples were S. aureus. The bacteria counting results (Figure 5A) showed that both 
the Ag0 and Ag1 membranes did not kill the bacteria, whereas the Ag5 membranes 
significantly decreased the number of bacteria in the membranes and the surrounding 
tissues. Besides, the decrease of the bacterial amount was continued to 0 for most 
samples in Ag5 group. The gram staining results (Figure 5C) displayed obvious 
bacterial aggregations in the tissues around Ag0 and Ag1 membranes, but fewer or no 
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bacteria could be found around the Ag5 membranes. Moreover, a correlation between 
bacterial counting and the silver amount in each capsule revealed that no bacteria 
could survive when there was more than 250 ng of silver per capsule (Figure 5B).
Figure 5 |  Results from in vivo antibacterial evaluation. (A) The bacteria counting result. 
The dashed line indicates the original inoculated bacterial amount. Data are 
shown as mean ± SEM. * indicates P < 0.05, ** indicates P < 0.01. (B) The total 
residual silver content correlated with the bacterial count result in the tissue 
capsules. (C) The Gram staining of sections. The red dots are cell nuclei. The 
green area are cytoplasm structures. M represents the implanted membranes, 
and the dark purple dots, indicated by pink arrows, are Gram positive bacteria. 
Scale bar: left 200µm, right 50 µm. 
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3.5  In vivo wound healing
 Figure 6 |  (A) the representative macroscopic images of wounds on day 0, 4, 7, 11 and 14 after 
surgery. The sizes of redish splints are inner ø12mm and outer ø22mm. (B) the % 
original wound area quantified from macroscopic images. The quantification of 
(C) collagen formation, (D) vessel density, and (E) macrophage density. Data are 
shown as mean ± SD. ** indicates P < 0.01.
The wound healing upon the coverage of rat full-thickness skin wounds with different 
membranes was evaluated. All the wounds healed in 2 weeks, including the sham 
group (Figure 6A). The wound healing rate in Figure 6B showed that no significant 
differences were found among the wounds covered with membranes. However, the 
Ag1 and Ag5 groups showed a faster healing compared to sham control. Histologically, 
a similar healing pattern was displayed for all the wounds (Figure 7). Overall, abundant 
granulation tissue characterized by new connective tissues and microscopic blood 
vessels were observed by visual inspection of the wound area; epidermis covered 
the wounds partially on day 4 and totally on day 14. Furthermore, the formation of 
collagen, new vessels, and the presence of macrophages was histomorphometrically 
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quantified in Figure 6C-E. No significant differences were found in the wound area 
among all the membrane groups regarding collagen formation, vessel density, and 
macrophage density.
 
Figure 7 | The wounds area after H&E staining. E: epidermis; D: dermis; W: wound area.
4 Discussion
Silver nanoparticles have been widely used in medical devices such as wound 
dressings thanks to their antimicrobial properties. However, no consensus has 
been reached on the efficacy and safety of AgNPs incorporation [6,7]. To decipher the 
potential of the AgNPs, the present study adopted AgNPs incorporated chitosan-based 
membranes and focused on exploring their antibacterial property and wound healing 
ability both in vitro and in vivo. It was found that the proteins and inorganic ions had 
a strong influence on the release of silver, and consequently altered the antibacterial 
property of the tested membranes. Furthermore, incorporation of AgNPs enhanced the 
antibacterial property of the chitosan-based membranes both in vitro and in vivo, but 
did not alter the wound healing effect of the membranes. 
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In our study, the chitosan-based membranes were successfully electrospun with a 
uniform nano-fibrous structure, and the AgNPs was confirmed to be homogeneously 
distributed in the fibers by TEM. This formation of AgNPs can be attributed to the 
reduction of silver nitrate by chitosan [26]. 
In biological systems, the presence of ions and proteins, of course, is inevitable. In this 
study, we selected PBS and FBS as representative solutions to explore the influence 
of inorganic ions and proteins on the silver release from the AgNPs-incorporated 
chitosan-based membranes. PBS is composed of 10 mM of PO
4
3‐, 137 mM of NaCl, 
and 2.7 mM of KCl; FBS has a similar ion-composition to PBS but with ample proteins 
[27]. After immersion, the PBS immersion did not alter the thickness of the membranes 
and kept the complete fibrous structure with only some silver salts deposition on 
the surfaces. The silver element can be detectable on the surface of the membranes 
with EDS and a continuous silver release was detected during the detection period. 
Subsequently, the AgNPs incorporated membranes showed antibacterial properties 
through the whole period. Together, this suggests that the inorganic ions, either 
bonding with silver ions to easily form water-insoluble salts or not, do not compromise 
the antibacterial property of AgNPs incorporated membranes. 
In contrast, the FBS immersion covered the fibrous structure of membranes with a 
thick layer of proteins, which hid the fibrous structure completely after 7 days. The 
FBS immersion resulted a significantly larger amount of released compared to PBS 
immersion. The silver was not detectable on the surface since day 4 and the silver 
was not detectable in the released medium after certain times (i.e. 1 day for the Ag1 
group and 7 days for the Ag5 group) as well. Correspondingly, the AgNPs incorporated 
membranes in our study lost their antibacterial property after 4-day and 7-day serum 
immersion for the Ag1 group and the Ag5 group, respectively. Combining the silver 
release and the antibacterial property, it may suggest that (1) the released silver is 
responsible for the antibacterial property of incorporated AgNPs and the release 
profile may well anticipate the antibacterial efficacy of silver incorporated materials, 
and (2) choosing a release medium similar to biological conditions is pivotal to 
evaluate the antibacterial potential of AgNPs incorporated materials.
To elucidate the possible mechanism of the silver release from the membranes, an 
allometric power growth equation (y = ktn) was fitted with adjusted R2 of more than 
0.95 to all the groups except FBS-Ag1 due to an insufficient number of data points 
(Table 1). The Power law or Korsmeyer-Peppas model (M
t
/M
∞
 = ktn) is a  simple semi-
empirical equation to describe the drug release from polymeric systems [28,29]. In this 
equation, k is a constant relating to the structural and geometric characteristics of 
the release system, and n is the release exponent indicating the mechanism of drug 
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release [28]. Ideally, the release is totally controlled by a Fickian diffusion when n is 
equal to 0.45. Clearly, when the exponent n takes a value of 0, the total drug release 
amount is constant which is only dependent on the dissolution of the drug; on the 
other hand, when n takes a value of 1 indicates that the release rate is independent 
of time corresponding to zero-order kinetics [28]. The PBS immersed membranes 
showed a release exponent (n) smaller than 0.45, suggesting that the silver release 
kinetics better followed the mechanism of diffusion, but were restricted by temporary 
supersaturation of drugs in the release medium, which happens commonly for poorly 
water-soluble substances [30]. The sparingly water-soluble salts such as silver chloride 
and silver phosphate are likely formed due to the bond between the released silver 
ions and the available chloride or phosphate ions in PBS [9]. Besides, a value of n 
between 0.45 to 1 can be regarded as an indicator for boundary conditions such as 
the presence of a stagnant layer or a net on the release surface [29]. The FBS immersed 
membranes showed a release exponent of 0.61, indicating the formation of a stagnant 
layer on the membranes and, indeed, a protein layer was displayed in the SEM images. 
The formation of the protein layer may be explained by a well-known hypothesis called 
the Vroman Effect, which postulates that small and abundant molecules will be the 
first to coat a surface, and molecules with higher affinity for that particular surface 
will replace them over time [31]. Compared to PBS, the relatively faster silver release in 
FBS could be driven by the consumption of free silver ions due to the strong affinity of 
silver ions to the thiol groups, which exist abundantly in serum proteins, e.g., cysteine, 
homocysteine, and glutathione [32-35]. The formation of protein layers around the 
materials altered the silver release profiles. 
Based on the above information, the potential mechanism of the interaction of AgNPs 
incorporated membranes with biological solutions may be illustrated in Figure 8. When 
the AgNPs incorporated membranes are exposed to a buffer solution, the silver release 
is dominated by diffusion, but mostly limited by solubility equilibrium. In contrast, the 
exposure of silver incorporated membranes to protein abundant solutions can result 
in the formation of protein layers on the membrane surface and simultaneously the 
chelation of silver ions by proteins would result in a fast release of silver. Over time, the 
protein layers grow thicker and eventually become a barrier to slow down and even stop 
the release of silver. As such, the alteration of protein layers on the silver release may 
affect the antibacterial efficacy and biological performance of the materials. Together, 
this suggests that special attention should be paid when applying silver-containing 
materials in a protein-rich environment, where the antibacterial ability of silver might 
be blocked by the formation of a thick layer of protein around the constructs.
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Figure 8 |  A schematic model that proposes a potential mechanism of silver release 
after PBS and FBS immersion.
A rat subcutaneous intra-operative contamination model was selected to explore the 
antibacterial efficacy of the AgNPs-incorporated chitosan membranes in vivo. In the 
present study, we selected the subcutaneous intra-operative contamination model 
considering that the sealed subcutaneous environment provides a microenvironment 
with biological fluids, such as tissue fluids and blood from surgery, and a reliable 
bacterial counting [36]. Despite the large amounts of S. aureus inoculation at the 
implantation site, AgNPs incorporated membranes showed a dose-dependent 
antibacterial property evidenced by the bacterial decrease in Ag5 group and no 
bacterial decrease in Ag0 and Ag1 group. Most samples of the Ag5 group continuously 
decreased the bacterial amount to 0 from day 7 to 28, suggesting a continuous 
antibacterial effect in vivo even after 7 days. Interestingly, our in vitro antibacterial 
test showed that both the Ag1 group and the Ag5 group had a stronger antibacterial 
property than the Ag0 group, and the serum immersion resulted that the Ag5 
membranes had a ZOI only until day 7 and Ag1 membranes did not have ZOI. This 
discrepancy of the sustained antibacterial efficacy may be due to the different protein 
contents among tissue fluids, PBS and FBS [37]. Therefore, we can speculate that the 
biological fluids may play an important role in the antibacterial property of silver for 
biomedical applications. 
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A rat excisional skin model was used to evaluate the effect of the membranes on the 
wound healing. Despite all the wounds healed in 2 weeks, the Ag1 and Ag5 groups 
showed a faster healing compared to sham control, which might be due to a synergistic 
effect of both chitosan and AgNPs since both are reported to be able to promote 
wound healing [10,38-40]. Although the wounds were macroscopically healed on day 14, 
the remodeling of wounds was still ongoing: the newly formed tissues in the wound 
area were mostly granulation tissue, but not structural dermal tissues as in the normal 
skin. Furthermore, no significant differences were histomorphometrically found in 
the wound area among all membrane groups regarding collagen formation, vessel 
density, and macrophage density, which play important roles in the wound healing [41]. 
This result may suggest that the silver incorporation had no negative effect on wound 
healing. The anti-inflammatory effect still needs to be proven. 
5 Conclusions
Silver nanoparticles incorporated chitosan-based membranes have been fabricated. 
The AgNPs incorporated membranes showed a sustained release of silver ions for at 
least 28 days in phosphate buffer saline whereas they displayed a silver release profile 
of fewer than 7 days in the fetal bovine serum. In vitro antibacterial results confirmed 
that the AgNPs-incorporated membranes had antibacterial properties corresponding 
to the silver release profile. These results indicated a potential mechanism that the 
silver bonding ions can restrict the silver release through solubility equilibrium 
whereas the proteins layer can first accelerate the silver release by chelation the 
silver ions and then hamper the silver release as the protein layer becomes thicker 
to be a barrier to block the silver release. Therefore, special attention should be paid 
to the proteins when the antibacterial efficacy is evaluated in vitro. Indeed, further 
in vivo evaluation confirmed that a high amount of AgNPs is necessary to achieve in 
vivo antibacterial efficacy. Moreover, the wound healing model displayed that AgNPs 
incorporated membranes did not alter the wound healing rate and tissue response. 
Our results suggest the AgNP incorporation can enhance antibacterial efficacy of 
biomaterials while having good wound healing ability. 
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1 Introduction
External fixation in orthopedics can be used for the treatment of comminuted 
fractures, open fractures, osteomyelitis, nonunion or pseudarthrosis, lower-extremity 
deformities, limb length inequality, and arthrodesis [1]. Due to the transcutaneous or 
percutaneous nature of the external fixators, there is a high risk of pin-tract infection 
(PTI) [2]. PTI is an almost inevitable problem of external fixation. The rate of PTI, ranging 
from 10 - 53.3%, is rather high in comparison with other infections associated with 
permanent implants such as prosthetic joint infections (<2%) [3,4]. The standard 
treatment of PTI is systemic administration of antibiotics. However, the existence of the 
pin facilitates the occurrence of infection, which are difficult to eradicate by systemic 
antimicrobial treatments [5]. Additionally, the systemic use of high doses of very potent 
antibiotics can cause irreversible damage to organs [6]. The frequent use of antibiotics 
has also high risk of fostering bacterial resistance, which has become a major global 
healthcare problem [7]. 
As PTI initiates with the bacterial adhesion and colonization on the pins [8], various 
approaches to improve the percutaneous have been proposed [2,3,9-11]. However, as 
a material, which allows permanent epithelial and connective tissue attachment 
is not yet available, the prevention of infection by creating an infection-resistant 
percutaneous seal has still not been successful [12]. The strategy to manufacture 
pins with antibacterial properties is another approach [1,13]. Incorporation of 
antibacterial agents to pins requires the pins to be altered either by depositing drugs 
in a hollow porous design, which inevitably compromises mechanical properties 
and requires complicated fabrication processes [14-17]. An alternative method is the 
use of antibacterial pin sleeves, which can function as an antibacterial barrier [18,19]. 
Voos et al. implanted pins contaminated by Staphylococcus aureus (S. aureus) 
in the iliac crests of goats and then provided them with tobramycin-impregnated 
polymethylmethacrylate sleeves [18]. They found that the antibacterial pin sleeves 
prevented the development of PTI up to 15 days [18]. Although antibiotics are the most 
frequently used drugs, they are associated with some problems, as mentioned already 
above. Antibacterial agents, like silver or chlorhexidine, can be an option to avoid the 
problems with antibiotics [16,20]. Our previous study showed that silver/chlorhexidine-
loaded membranes showed excellent antibacterial efficacy in vitro [21], and thus may 
be a promising candidate for antibacterial sleeves to prevent PTI. 
The evaluation of antibacterial efficacy necessitates the use of animal models before 
going into clinical trials [22-26]. For this purpose, a suitable percutaneous animal model 
is needed, which must have the following characteristics: (1) a consistent induction of 
infection, (2) stably fixed implants, and (3) maintenance of the percutaneous passage 
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throughout the experimental time. It has been proven that consistent infection rates 
can only be induced by bacterial inoculation [14,27]. We recently reviewed existing 
percutaneous animal models and found that in most models an implant location was 
used, where the (sub)cutaneous tissues were very thin, such as the scalp, dorsum, and 
medial part of tibia. In contrast, clinically external fixators are used at locations with a 
thicker tissue layer. Moreover, models report experimental periods varying from 3 days 
to 15 months [4], whereas pins clinically have to stay in place for 6-7 weeks [28]. Finally, 
the existing animal models report occasionally the occurrence of bone fractures 
due to the implant installation [14] as well as the loss of percutaneous status due to 
overgrowth of skin [27]. 
Therefore, the aim of this study was to construct a percutaneous animal model to 
decrease the large discrepancies between the animal test and clinical situation. We 
also applied this model to test whether: (1) silver incorporation in sleeves would 
reduce PTI in vivo with repeated bacterial challenges for 6 weeks, and (2) the addition 
of chlorhexidine would further reduce the PTI as compared to the silver-loaded sleeves 
alone. To this end, we designed titanium pins and implanted them in a percutaneous 
rabbit tibial model with repeated bacterial inoculations for 6 weeks. Before the start 
of the study, a pilot study was done to determine the proper implant location and 
the length of the enossal part as well as percutaneous part of the implant. The rabbit 
anterolateral tibia was selected as the implantation location, since there is a thick 
subcutaneous tissue. After measuring the diameter of the tibia (around 8 mm) and the 
soft tissue thickness (around 10 mm) on a cadaver, the implants was initially designed 
with a total length of 23 mm including an enossal part of 8 mm in length. However, such 
implants were found to be rapidly covered due to the overgrowth of skin. Therefore, 
the percutaneous part of the implants was extended by connecting 3 mm diameter 
tubes or rods to elongate the implants. Eventually, a total implant length of 40 mm 
was shown to be long enough to keep the implants percutaneous and was used for the 
study.
2 Materials and methods
2.1 Implant materials
The implants in this study were designed to represent external fixator pins. The 
diameter of the implant was 3 mm. The length of implants was 40 mm based on a 
pilot study to maintain a percutaneous passage (Fig. 1A&B). An 8-mm long thread of 
M2.5 × 0.45 was fabricated at the apical end of the implant, which was based on the 
measurement of tibial diameter in rabbit cadavers and a 1 mm wide slot was created 
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on the other end of the implants to facilitate the installation of the implants with a 
screw driver (Fig. 1C). All implants were made of grade 5 titanium alloy (Ti-6Al4V) 
using a milling machine and did not receive any further surface treatment (Jansen 
Machining Technology B.V., Valkenswaard, the Netherlands). The implants were then 
sequentially ultrasonically washed in 10% liquinox detergent (Alconox, New York, NY, 
USA), isopropanol, acetone, and ultrapure water (Millipore Corp, Bedford, MA, USA) to 
remove dirt and oil. After washing, the implants were autoclaved. 
The sleeves were prepared as previously reported [29]. Briefly, the chitosan based 
blend solutions were prepared by dissolving chitosan (degree of deacetylation = 90%, 
molecular weight = 200-400 kDa, Heppe Medical Chitosan, Halle, Germany), poly 
(ethylene oxide) (PEO, Molecular weight = 900 kDa, Sigma-Aldrich®, St. Louis, NI, 
USA), and silver nitrite (AgNO
3
, Sigma-Aldrich®) in 35% of acetic acid (99.9%, Boom 
BV, Netherlands)/ultrapure water (Millipore Corp, Burlington, MA, USA) solution at total 
solid concentration of 3 wt% with different mass ratios (Chitosan/PEO/AgNO
3
 = 60/40/0, 
60/40/1, and 60/40/5). After stirring overnight, the solutions were electrospun at a flow 
speed of 4 ml/h, a distance of 18.5 cm between collecting plate and spinneret, and a 
voltage of 28-30 kV. The electrospun membranes were further dried and crosslinked 
with glutaric dialdehyde (25 wt% solution in water, ACROS Organics™, Geel, Belgium) 
vapor at room temperature for 2 hours. After drying in a fume hood, they were cut into 
13 mm × 40 mm rectangular sheets (Fig. 1D) and named as Ag0 and Ag5 corresponding 
with their silver content, respectively. Thereafter, the sleeves with silver and 
chlorhexidine were prepared. For this purpose, an aliquot of 60 µl of 20% chlorhexidine 
digluconate in water (Sigma-Aldrich) was pipetted onto Ag5 sheets. These samples were 
subsequently air-dried in a fume hood overnight, and thereafter named as Ag5C. 
Finally, all samples were sterilized by 25 kGy γ-radiation (Synergy Health, Ede, The 
Netherlands).
2.2 Animals and experimental design
The animal experiment was approved by the Dutch Central Animal Experiment 
Committee (project license AVD10300 2015-241) and the work protocol (Protocol No. 
2015-0072-004) was approved by the Animal Experiments Committee of Radboud 
University according to the legal regulations as stipulated in the amended Animal 
Testing Act in the Netherlands and Directive 2010/63/EU of the European Parliament 
and of the Council. 
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Figure 1 |  The model construction. (A) the final design of the implants, with sizes shown in 
mm. (B) The implanted materials: from left to right: the titanium implant, Ag0, 
Ag5, and Ag5C sleeves. (C) Macroscopic image of implant status immediately 
after surgery. 
Thirty-three 12-week-old New Zealand white rabbits (2.6 - 3.6 kg) were randomly 
assigned to the three groups with 7, 13, and 13 rabbits for Ag0, Ag5, and Ag5C group, 
respectively. Randomization was achieved using a computerized random sequence 
generator (www.random.org). The blinding was achieved by an independent 
investigator, who labeled the samples and assigned the samples to the animals, but 
did not participate in the data collection and analysis process. After data analysis, the 
sample assignment was disclosed. 
Before surgery, the rabbits were acclimatized for two weeks, housed in the standard 
conditions and received food and water ad libitum. 
2.3 Surgical techniques
All rabbits received analgesic before surgery via subcutaneous injection of 
enrofloxacin (8 mg/kg) and carprofen (4 mg/kg). After 30 min, dexmedetomidine 
(50 µg/kg) and ketamine (10 mg/kg) were injected into the rabbit’s semitendinosus 
or semimembranosus muscle. Surgery was performed under general inhalation 
anesthesia with a combination of isoflurane, nitrous oxide, and oxygen. 
The right hind leg was shaved and prepared for surgery by scrubbing with a povidone-
iodine scrub for three times. The animal was immobilized on its back. A longitudinal 
incision (about 10 mm in length) was made on the anterior lateral middle third of the 
tibia. After exposing the bone with blunt dissection, a pilot hole was drilled completely 
through the tibia. The bone preparation was performed at 800 revolutions per minute 
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with continuous external saline cooling [30]. The implant was screwed into the prepared 
hole. The pre-assigned sleeve samples were wrapped around the implant and inserted 
in the skin site. The finally applied sleeve consisted of four layers. After suturing 
the incision with 4-0 sutures (Vicryl, Ethicon Inc., Somerville, NJ, USA), the sleeves 
were exposed about 2 mm above the percutaneous exit site (Figure 2C). No further 
precautions were taken to cover the exit sites, since regular observation in a pilot 
study showed that the rabbits did not try to lick or chew the implants.
To recover the rabbit from anesthesia, atipamezole (500 µg/kg) was injected 
subcutaneously into the rabbit’s neck region. For postoperative pain management 
and infection prevention, carprofen (4 mg/kg) and enrofloxacin (8 mg/kg) were 
subcutaneously injected into the neck region after 12 and 24 hours. 
2.4 Bacterial challenge 
After 2 weeks and weekly thereafter, 50 µl of ~2×107 colony forming units (CFU) of S. 
aureus (ATCC™ 25923) suspension was injected into the percutaneous exit site of the 
implants. The bacterial suspension was always freshly prepared before inoculation 
by dispersing S. aureus ATCC™ 25923 colonies in sterile saline (0.85% NaCl w/v in 
water) at a density of 0.60 McFarland standard value and then diluted 10 times. The 
concentration of bacterial suspension was confirmed by bacterial counting on agar 
plates.
2.5 Clinical evaluation
The general condition of the rabbits such as weight and activity were evaluated weekly 
after surgery and the percutaneous exit site of the implant was inspected weekly for 
symptoms of infection. During these inspections, the appearance of the exit site and 
percutaneous tunnel was registered using a systematic list (Table 1) modified from a 
previous study [31]. 
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Table 1 | Grading scale for the appearance of the implant exit sites 
Exit site Score
skin color
Normal 1
Pink 2
Red irritated 3
Drainage
No drainage 1
Little exudate 2
Accumulated exudate (fluids) around the implant 3
The dehiscence of wounds around implants
No dehiscence with skin tightly surrounding the implant 1
Irregular dehiscence with small exposed wounds 2
Large irregular dehiscence with large wet wounds 3
Swelling
Not obvious 1
 Obvious 2
 
2.6  Tissue processing and histology
After 6 weeks, all animals were euthanized by an overdose of pentobarbital. The right 
hind leg was shaved and the skin around the implant exit sites was disinfected with 70% 
ethanol. The tibia of 2 rabbits from each group was cross-sectioned at 2 cm distance 
from the implants using an oscillating bone saw. Subsequently, these specimens were 
immersed in 10% neutral formaldehyde for 48 hours, dehydrated in a graded series 
of ethanol (70–100%) and then embedded in polymethylmethacrylate (PMMA). After 
polymerization, thin sections of 10 µm were prepared in a cross-sectional direction 
of tibia and along the longitudinal direction of the implants using a diamond blade 
microtome (Leica Microsystems SP 1600, Nussloch, Germany). Three sections of each 
specimen were stained with methylene blue and basic fuchsin. 
For the other animals, the implants were first unscrewed and immersed into 5 ml 
physiological saline for bacterial counting tests as described in Section 2.7. The 
percutaneous implant tunnel was maintained by inserting a wooden stick in the hole as 
left in the cortical bone after removal of the implant. The tissues with the stick, including 
tibia and skin, were then retrieved again by cutting at 1.5 cm distance from the implant 
location. After retrieval, all tissues were immersed in 10% neutral formaldehyde for 48 
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hours, and then in 70% ethanol for at least 2 days. Then, the tissues were decalcified 
by a decalcification system (TDE 30, Sakura Finetek Europe B.V, Alphen aan den Rijn, 
the Netherlands) for 7 days and dehydrated in series of ethanol. After the wooden 
stick was removed, the specimens were immediately embedded in paraffin. Finally, 
5 µm-thick sections were cut through the longitudinal axis of the percutaneous pin 
tract using a Leica RM 2165 Microtome (Leica Biosystems, Wetzlar, Germany). For each 
sample, two sections were stained with routine hematoxylin and eosin (H&E) staining 
for general tissue observation and Brown-Brenn modified Gram staining to show the 
bacteria. For H&E staining, paraffin sections were deparaffinized in xylene, rehydrated 
to water, stained with Delafield’s hematoxylin, dehydrated again to 96% ethanol, and 
stained with eosin. For Gram staining, paraffin sections were deparaffinized in xylene, 
rehydrated to 96% ethanol, treated with ammonium ethanol, rinse in water, stained 
with filtered Hucker-Conn solution, rinsed with water again, treated with Lugol, rinsed 
in water and dried, treated with 60°C acetate acid ethanol, rinsed with water, and 
stained with Twort solution. After staining, the sections were sequentially rinsed in 
ethanol, xylene, and mounted in DPX (BDH Laboratory Supplies, Dorset, UK). 
To quantify the bacterial amounts in the tissues, three images were taken at locations 
close to the subcutaneous connective tissue, muscle, and bone as shown in Fig 6A. 
Subsequently, the bacterial amount and tissue area were quantified from the images 
with macros created in Fiji (NIH, Bethesda, MD, USA). The bacterial number was further 
normalized by the tissue area as:  bacterial density = log (total of counted bacteria) / 
area of tissue in mm2).
2.7 Microbiological evaluation
Immediately after unscrewing of the implants, these implants were immersed in 5 ml 
saline and vortexed for 30 s, ultrasonically treated for 5 min, and vortexed again for 
30 s to dislodge the bacteria [32]. To count the bacterial number, a serial dilution of 
the suspensions was inoculated on Columbia Blood Agar with 5% Sheep Blood plates 
(CBP, Becton Dickinson, Franklin Lakes, NJ, USA), which are suitable for all types of 
bacteria to grow. For suspicious colonies, matrix-assisted laser desorption/ionization 
with time-of-flight mass spectrometer (MALDI-TOF, Billerica, MA, USA) was further 
applied for bacterial identification.
2.8 Statistics
All data were reported as mean ± standard deviation and were analyzed by GraphPad 
Prism 5.0 (GraphPad Software Inc., San Diego, USA) or R version 3.4.3. The animal 
weight data were compared with two-way analysis of variance (ANOVA). The grading 
score of clinical symptoms was compared by a linear mixed model using the lme4 
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library. Based on the data distributions, the quantified bacterial data from tissue slides 
and implants were compared by Student’s t-test and Mann Whitney test, respectively. 
Differences were considered statistically significant at p < 0.05.
3 Results
3.1 Characterization of the sheets
The chitosan/PEO membranes with or without silver were successfully prepared. Ag0 
and Ag5 sheets displayed uniform and defect-free fibrous structures (Figure 2A&B). 
With the addition of CHX (Ag5C group), the chitosan-based fibers remained intact 
but the pores between the fibers were observed to be more filled with chlorhexidine 
(Figure 2C).
 
 Figure 2 |  The scanning electron micrographs of the sleeves made by electrospinning of 
chitosan-based solutions: (A) Ag0 group, (B) Ag5 group, and (C) Ag5C group. 
Scale bar: 1 µm.
Figure 3 |  General conditions. (A) the implant remained percutaneous at sacrifice.(B) The 
implant exit site at sacrifice. (C) X-ray image of an implant in the tibia at sacrifice. 
(D) the collected implant with the sleeve. (E) The weight change of rabbits during 
the test period. 
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3.2 General observation of the animal’s health
All rabbits survived throughout the entire evaluation period, and all implants stayed 
stable and percutaneous with approximately 12-mm extrusion above the skin surface 
(Figure 3A-C). However, the soft tissues around the exit-site were swollen, which 
made that the sleeve did not longer protrude above the skin surface. The presence 
of the implants did not disturb normal movement of the rabbits, such as walking and 
jumping. The first week after surgery, none of the rabbits gained weight, but they 
continuously gained weight from the second week on (Figure 3E). No significant 
differences between the various implant groups were detected for the growth rate of 
the rabbits (P = 0.4269). When the implants were finally retrieved, the sleeves were 
still found to be present and attached to the implants (Figure 3D).
Figure 4 |  The scores of clinical symptoms based on (A) skin color, (B) drainage, (C) 
dehiscence, and (D) swollen. The sums of scores are shown in (E). A linear mixed 
model was adopted to analyze the summed scores. Ag0 vs Ag5 was significant at 
P = 0.0095; whereas Ag5 vs Ag5C was not significant at P = 0.2489.
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 3.3 Clinical analysis of the percutaneous exit site
The clinical inflammatory symptoms of the percutaneous exit site of the implants were 
evaluated according to the grading scale listed in Table 1. The total score of infection 
symptoms was selected to represent the inflammatory status as shown in Figure 4. 
The inflammatory status at day 14 was a baseline before bacterial challenge. At 
day 14, 3 out of 7, 4 out of 13, and 3 out of 13 rabbits in Ag0, Ag5, and Ag5C groups, 
respectively, had a score of 4, meaning no inflammation was seen. Further analysis 
revealed that no statistical difference was found among the three groups (P = 0.6634). 
After bacterial inoculation, the total score of the infection symptoms increased and 
all the percutaneous exit sites in the Ag0 group were infected as depicted in Figure 4. 
A significant difference existed between Ag0 group and Ag5 group (95% confidence 
intervals (CI): [0.228, 1.635], P = 0.0095) whereas no significance was found between 
Ag5 group and Ag5C group (95% CI: [-0.242, 0.935], P = 0.2489). 
3.4 Histological observation
Light microscopical images of the PMMA embedded specimens are depicted in Figure 
5A-C and reveal that the percutaneous part of the implants is surrounded by about 
20-mm thick soft tissues. The screw part was found to penetrate the tibial cortices 
bilaterally. New bone formation was observed around the enossal part of the implants, 
which was penetrating the medullar cavity. The newly formed bone as well as the 
cortical bone were in close contact with the implant surface without an intervening 
fibrous tissue layer. Furthermore, new bone formation was observed at the apical 
side of the implant. This newly formed bone could easily be discerned from the native 
bone. Further observations on the HE stained slides showed that the sleeves could 
be detected as a small gap in between the implant surface and soft tissue (Figure 
5A). The tissue response to the implants wrapped with chitosan-based sleeves was 
similar for all animals. A representative histological section of the paraffin embedded 
specimens is shown in Figure 5D. The sections indicated that after implant extraction, 
no residual sleeve material was observed in the implant tunnels. The sleeves 
remained attached to the implants (Figure 3D). Further, the tissues surrounding the 
percutaneous passage were found to be composed of a thick layer of the connective 
tissue, which was infiltrated with inflammatory cells (Figure 5E). The surface of the pin 
tract was observed to be covered with epithelial cells. The epithelial downgrowth by 
visual inspection was usually seen up to halfway the pin tract tunnel. However, it never 
progressed until the bone surface. 
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Figure 5 |  Cross-sections of PMMA embedded tibia with implant from (A) Ag0 group, 
(B) Ag5 group, and (C) Ag5C group. i: implant, b: bone. (D) Representative 
microscopic graph of the tissues around the extracted implant after H&E 
staining. s: skin, m: muscle, b: bone, e: epidermis, c: connective tissue, t: 
implant tunnel. Scale bar: 5 mm. (E) The magnified image of connective tissue in 
the square area of D. The arrow head points to the inflammatory cells. Scale bar: 
100 µm.
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Figure 6 |  (A) Bacterial counting based on the Gram staining. Three images from locations 
near skin, muscle and bone were made and the bacteria were quantified. S: 
superficial layer, M: middle layer, D: deep layer. Scale bar: left 2 mm, right 50 µm. 
(B) Bacterial density of each group as evaluated by Gram staining. Statistical 
analysis was done by Student’s t-test. * indicates P < 0.05 between Ag0 group and 
Ag5 groups.
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3.5 Bacterial density in the percutaneous passage
After Gram staining, the cytoplasm structures were stained in light green and the 
bacteria were stained in dark purple. The bacterial density in the tissues was quantified 
by selecting three representative images from the superficial, middle, and deep part 
of the tissue tunnel (Figure 6A). An average bacterial density of the three parts was 
further calculated to represent each sample. Figure 6B showed that a significant 
difference existed between Ag0 group and Ag5 group (P = 0.0223), but not between 
Ag5 group and Ag5C group (P = 0.6685).
3.6 The microbiological evaluation
Finally, the bacteria attached to the implants were isolated, identified, and quantified. 
The bacteria were identified by the colony appearance and the MALDI-TOF. Besides 
the inoculated bacteria i.e. S. aureus ATCC 25923, other bacteria, mostly Enterococcus 
faecalis strains and other S. aureus strains, were identified. Based on this finding, 
counting was divided into two categories, i.e. S. aureus vs. other bacteria (Figure 
7). Significant differences existed consistently between Ag0 group and Ag5 group 
regarding inoculated S. aureus (P = 0.0444), other bacteria (P = 0.0185) and total 
bacteria (P = 0.0183); whereas no significant differences were found between Ag5 
group and Ag5C group for either inoculated S. aureus (P = 0.7369), other bacteria (P = 
0.3809) or total bacteria amount (P = 0.2739).
  
Figure 7 |  The number of bacteria found on implants using a CFU plating counting method. 
Statistical difference was compared by Mann Whitney test. * indicated P < 0.05 
between Ag0 group and Ag5 groups.
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4 Discussion
The current study focused on evaluating the efficacy of drug-loaded antibacterial 
sleeves for the prevention of PTI for 6 weeks in vivo. A percutaneous rabbit tibial model 
was successfully constructed with the use of bacterial inoculation. The obtained data 
indicate that the silver loaded chitosan-based sleeves can reduce the inflammatory 
response of the pin tract significantly even after repeated bacterial challenge. 
However, the addition of chlorhexidine did not improve the antibacterial efficacy of the 
silver-loaded sleeves.
Several remarks can be made regarding the implant design. First, the 2.5-mm diameter 
implant screw survived throughout the study period without compromising the 
mechanical strength of the rabbit tibia, which corroborates with a previous study 
[14]. Moreover, the screw with a length of 8 mm proved to be capable to stabilize 
the implants bilaterally. However, in contrast to a previous rabbit study [6], a 5 mm 
exposure length above the skin surface appeared not to be enough to keep the implant 
percutaneous as evidenced by the coverage of implants from the swollen soft tissue 
in our pilot study. This discrepancy may be attributed to the post-operative swelling 
of the thicker soft tissue layers (estimated around 13-mm) in the anterior lateral tibia, 
which differs from the thin soft tissue layer of the medial tibia. Therefore, based on this 
study, we propose that an exposure length of at least equivalent to the thickness of 
soft tissue is required to keep implants percutaneous. 
The observations of the bone response showed that the enossal part of the implant 
penetrated the tibia bilaterally and kept the implants stable. The cortex at the apical 
(implant tip) side apparently became noticeably thicker, as confirmed by histology, 
whereas the cortex on the other side did not change obviously. The thickening of the 
cortex at the apex of the implants and the upgrowth of bone along the implant surface 
at the endosteal side of the cortex is probably caused by damage to the periosteum 
and endosteum during the drilling procedure and implant installation. It is known 
that the periosteum and specifically the attached cambium layer play an important 
role in osteogenesis [33]. Moreover, the newly formed bone and the cortical bone were 
in close contact with the implant surface without an intervening fibrous tissue layer, 
which explains the stability of the implants. In addition, the bone formation around 
the screws was also indicative that the release of silver and chlorhexidine from the 
sheets did not affect the bone healing, which corroborates previous results [34,35]. 
Although the intramedullary bone formation and close bone-implant contact was not 
the main interest of the current study, it verified our success in constructing the rabbit 
percutaneous model. 
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The baseline of clinical symptoms at day 14 showed that the percutaneous passage 
did not spontaneously evoke an inflammatory response in all animals. This proved the 
necessity of bacterial inoculation to initiate infection, which corroborates previous 
studies [14,27]. After bacterial inoculation, a 100% bacterial infection rate in the 
control group (Ag0) was verified by visual observation of inflammatory parameters, 
microbiological, and histomorphormetrical tests. The microbiological identification 
further substantiated that the final bacteria colonizing a wound do not only include 
inoculated strains (in this case, the S. aureus) but also other environmental bacteria, 
which again agrees with previous findings [4,14]. Although the infection rate of 100% 
in the control group confirmed the effectiveness of the bacterial inoculation, we 
cannot conclude that the inoculated bacteria are solely responsible for the further 
development of the infection. 
Regarding the study results, the inflammatory symptoms at the percutaneous exit site 
formed the most important parameter to indicate the occurrence of infection. Overall, 
all rabbits showed inflammation of the percutaneous passage during the study periods 
after multiple challenge of large quantities of bacteria and the sleeves were extracted 
together with the implants at the end of the study (Figure 3D). This maintenance of the 
sleeves may be attributed to the slow degradation of the chitosan-based membranes 
as evidenced by that the chitosan based membranes were implanted remained 
intact after subcutaneous implantation for 12 weeks in rabbits [29]. Despite the 
repeated inoculation, the silver loaded sleeves did show a significantly lower grade 
of inflammation than the sleeves without silver. Similar decrease in the numbers of 
colonized bacteria on the percutaneous implants and the surrounding tissues was 
confirmed by microbiological and histomorphometrical analysis. This antibacterial 
effectiveness of the silver loaded sleeves can be attributed to the sustained release of 
silver, as evidenced in our previous silver release study [21] and previous studies from 
other groups [36-38]. However, the incorporation of silver in biological systems might be 
risky in the sense that silver ions are released in the cell membrane and thus may lead 
to cytotoxicity effects, incite immunological responses and disrupt cell growth activity 
[39-41]. Indeed, silver showed a dose-dependent cytotoxicity in our previous study, but 
the silver loaded membranes adopted in this study displayed antibacterial property 
without noticeable cytotoxicity in vitro [29]. Therefore, the lower grade of inflammatory 
response evoked by the silver loaded sleeves could be attributed to the fewer bacteria 
present in the wounds surrounding the silver loaded sleeves. Even without additional 
wound cleaning, the silver loaded sleeves still succeeded to lower the inflammatory 
response and decrease the number of the colonized bacteria of the pin tract. It can be 
hypothesized that this effect of such sleeves will even be more evident in the human 
clinical application, where daily pin care is routinely carried out and bacterial exposure 
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is much lower [8]. Therefore, this effectiveness encourages further (pre)-clinical 
evaluation of the silver loaded sleeves.
In contrast, the further post-loading of chlorhexidine on the sleeves failed to enhance 
the long-term antibacterial ability of the sleeves. Since the chlorhexidine loaded 
membrane showed antibacterial effect in vitro [21], this failure can most likely be 
attributed to the way the chlorhexidine was loaded into the membranes. The SEM 
pictures indicated that the chlorhexidine was stored in the membrane fibers, which 
resulted probably in the immediate release of chlorhexidine from the sleeves after 
implant installation [21] and the residual chlorhexidine in the pin tract when the bacteria 
were inoculated to challenge the wounds. To clarify this effect, further research 
is needed either by achieving a sustained release of chlorhexidine or by frequently 
change of the sleeves. Finally, we should acknowledge that our study still has a 
limitation of lacking pin care routine. This lack of infection control routines together 
with our repeated inoculation with large amounts of bacteria may be the reason that a 
complete eradication of the bacteria was not achieved. Therefore, we would suggest 
that future animal model, like in the human clinical application, should include regular 
pin care routine.
5 Conclusion
A consistent rabbit tibial model with repeated bacterial challenge was constructed 
successfully to evaluate antibacterial strategies to prevent PTI. This PTI model was 
characterized by an 100% infection rate, while the implants maintained stably fixed 
in the tibial bone, and without the loss of animals. The evidence from inflammation 
symptoms, microbiological bacterial counting, and histomorphometrical analysis 
together proved that a silver loaded chitosan sleeve can reduce the inflammatory 
response of the pin tract compared to a control sleeve without silver. However, the 
addition of chlorhexidine into the sleeve did not contribute to further reduction of the 
inflammatory symptoms. Consequently, the silver loaded sleeve seems suitable for 
further (pre-) clinical exploration.
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1 Introduction
The restoration of the maxillofacial defects is a challenge because of the complicated 
pre-existing anatomy of the skull [1]. Recently, the advance in 3-Dimensional 
(3D) printing with computer-aided modeling techniques has enabled to create 
accurate scaffolds that contour to the patient’s anatomical parts based on the 3D 
reconstruction of Computer Tomography (CT) scanning data [2,3]. Based on the baseline 
technology, type of machine architecture, and the material transformation physics, 
3D printing can be classified into 5 categories, i.e. vat polymerization, powder bed 
fusion, material extrusion, material jetting and direct energy exposition [3]. Among 
them, the pneumatic extrusion method (Fig. 1), which is a sub-category of material 
extrusion, is attractive for biomedical application as it requires only a small amount 
of materials, i.e. in a few milligrams compared to a few hundred grams for other 
technologies [3]. After the 3D reconstruction file is loaded to the 3D printer, the object 
can be concisely printed via controlling the movement of the syringe (x-, y-, z- motion). 
Subsequently, a viscous or semisolid slurries, made by mixing a solvent and polymer, 
e.g. alginate, polycaprolactone (PCL), polyglycolic acid (PGA), polylactic acid (PLA) 
and their copolymer poly(lactic-co-glycolic acid) (PLGA), is loaded into the syringe [4].
The applied pneumatic pressure can continuously extrude a microfilament from the 
viscous slurry via a fine nozzle. The printability of the slurry is controlled by parameters 
such as the slurry viscosity, nozzle diameter, the speed of nozzle movement and the 
pneumatic pressure [5]. The final architecture of the scaffold can be characterized by 
the shape of the micro-filament diameter, pore size and shape, total porosity, and pore 
interconnectivity etc. [6]. 
Such 3D designed polymeric scaffolds can be used to restore and regenerate bone 
defects. However, maxillofacial defects can originate from or are associated with 
infection, accompanied by bacterial colonization and inflammation [7]. Despite 
radical surgical debridement, removal of the infected area is often incomplete [8]. As 
a consequence, the residual bacteria may attach to the restorative materials to form a 
biofilm, which are difficult to eradicate [9]. Over the past decades, attempts have been 
made to prevent and cure infections by incorporating antibiotics into the materials 
during either primary or revision surgery [10,11]. However, the long-term patient 
exposure to low doses of antibiotics has a high risk of inducing antibiotic resistance. 
Alternatively, chemical agents such as silver have been used due to the much lower 
tendency to give rise to resistance [12]. For instance, silver phosphate (Ag
3
PO
4
) has 
been incorporated into polyurethane composites through an in situ forming method 
and exhibited strong antibacterial effects with satisfactory cytocompatibility [13]. 
To eradicate the organisms from infected surrounding tissues usually requires the 
release of effective antibacterial drugs for  3 to 4 days including a high initial burst 
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release during the first 2 days [14]. In addition to the infection, postoperative pain is an 
unavoidable symptom.  During the first postoperative 24 hours,  approximately 40% 
of the patients reported moderate to severe postoperative pain [15]. Although the pain 
decreased with time, the management of the postoperative pain can be important 
at home as it will  last longer than 24 - 48 hours [15]. Currently, the patients usually 
are administered strong pain killers, like opioids, to relieve the pain [16]. Albeit being 
effective, a large intake of opioids can induce respiratory depression, nausea, and 
vomiting. Therefore, multimodal analgesic regimens, such as local anesthetic-opioid 
combinations, have been proposed to control postoperative pain [17]. In particular, 
continuous postoperative application of lidocaine can have a preventive effects on the 
postoperative pain and reduce opioid consumption [18]. The elongation of the duration 
of analgesia to longer than 24 h might prevent the need for continuous analgesic 
catheters in some clinical settings [19].
 Figure 1 |  Schematic representation of the direct digital manufacturing process using 
an air pressure extrusion based additive manufacturing system. (A) A digitally 
designed 3D object. (B) A slurry is transferred to the printing syringe, sealed with 
a piston, and then driven by air pressure to form a filament, while the movement 
of the syringe in various directions controls the printing progress. (C) The final 
3D-printed object depicts the original design in A.
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To achieve an antibacterial and analgesic effect, it can be advantageous to incorporate 
both drugs in a bone scaffold, which achieves the drug release rates above the 
therapeutic thresholds [3]. In a microscale polymeric drug delivery systems, the drug 
transport is primarily driven by diffusion [20]. Therefore, an important way to control 
the drug release is the alteration of the diffusion distance [21,22]. Since the diffusion 
distance can be easily adjusted by modulating the filament diameter of the printed 
scaffolds, we hypothesize that the drug release rate can be changed by varying the 
filament diameter of the 3D printed scaffolds. However, no research work on this topic 
can be found in literature until now. 
In this study, we aimed to develop a polycaprolactone (PCL) scaffold loaded with 
Ag
3
PO
4
 to prevent infection and lidocaine for pain relief by one-step 3D printing. PCL 
was selected due to its biocompatibility and printability by a pneumatic extrusion 
method [5,23]. 3D printed PCL scaffolds loaded with Ag
3
PO
4
 and lidocaine were printed 
in a single step with extrusion nozzles of different sizes. The scaffold morphology, drug 
release profiles, antibacterial efficacy, and cytotoxicity were further evaluated.
2 Materials and Methods
2.1 Slurry preparation for printing
The slurries for printing were prepared by mixing PCL (Mn = 80 000 g/mol, T
m
 = 60 ˚C; 
Shenzhen Esun Industrial Co, Shenzhen, China), lidocaine (Sigma-Aldrich, St. Louis, 
MO) and Ag
3
PO
4
 (Strem Chemicals, Newburyport, MA) in dichloromethane (Kelong 
Chemical Reagent Factory, Chengdu, China). All chemical reagents used in this research 
were of analytical quality. The sample groups were named as Drug0, L2, L4, Ag1, Ag3, 
and Ag3L4 based on the drug (lidocaine and Ag
3
PO
4
): PCL weight ratio (see Table 1). 
Materials were dissolved for 2 hours and stirred in a fume hood until a filament of 
around 20 cm in length could be extruded. The shear viscosity of the slurry was further 
determined by a viscometer (NDJ-9S digital viscometer, Vetus Electronic Technology, 
Hefei, China) at a rotation speed of 1.5 rpm at 25 °C. A proper shear viscosity of the 
slurry for the extrusion of filaments had to range from 0.25 to 0.35 Pa•s.
chapter 6
126
Table 1 | The composition of the slurry for printing in different groups 
Materials\Group Drug0 L2 L4 Ag1 Ag3 Ag3L4
PCL (g) 10 10 10 10 10 10
Lidocaine (g) - 0.2 0.4 - - 0.4
Ag3PO4 (g) - - - 0.1 0.3 0.3
Dichloromethane (mL) 50 50 50 50 50 50
2.2 Scaffold fabrication
The scaffolds were printed using a pneumatic extrusion-based 3D printer (Regenovo 
3D Bioprinter, Hangzhou, China). The 3D printer was composed of a nozzle-connected 
printing head (syringe), pneumatic pressure controller and three-axis (x, y, z Cartesian 
coordinates) linear motion controllers. A digital file of a disc model (15 mm in diameter 
and 1.5 mm in thickness) was transferred to the printer, as the designed shape for the 
3D printed samples. During the printing process, the slurries were delivered through 
a nozzle (0.21 mm or 0.41 mm in diameter) at a speed of 4 mm/s with a constant 
pressure of 450 kPa. The slurries were laid down in a layer-by-layer manner to form 
the scaffolds, which were further labeled with 0.21 and 0.41, respectively. A degree 
of 90° was set between the lower and upper layers to generate a latticed pattern. The 
0.41 scaffolds were printed with an x- or y-motion step of 0.7 mm and a layer thickness 
of 0.2 mm (z-motion), while the 0.21 scaffolds were printed with an x- or y-motion step 
of 0.5 mm and a layer thickness of 0.1 mm. The printing was conducted under ambient 
conditions. After printing, all scaffolds were further dried in the fume hood overnight 
and then vacuum-dried for another 12 hours. 
2.3 Morphological characterization
The morphology of the scaffolds was assessed by scanning electron microscopy 
(SEM, JEOL 6500LV; JEOL, Tokyo, Japan). All samples were sputter-coated with a 
thin layer of gold prior to observation. The diameter of the filaments was quantified 
from four different SEM images at 35× using Fiji software (NIH, Bethesda, MD). The 
scaffolds were cross-sectioned to further observe the drug status in the filaments. 
Energy Dispersive X-ray spectroscopy (EDX, Oxford Instruments, Abingdon, UK) was 
applied for analysis of elemental composition of the filaments. The 3D structure was 
reconstructed following micro-CT scanning (µCT40, Scanco Medical, Brüttisellen, 
Switzerland). The samples were scanned at 45 kV and 175 µA with a slice increment of 
19 µm. The 3D images were reconstructed from a series of serial 2048 × 2048 bitmap 
images using Software CTAn and CT Vol Realistic 3D Visualization (Bruker microCT, 
Kontich, Belgium). 
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2.4  Drug release
Disk samples (n = 5 of each type) were weighed and placed into 15 mL Falcon™ 
conical centrifugal tubes containing 10 mL phosphate buffer saline (PBS, Gibco™, 
Invitrogen Corp., Paisley, Scotland). The tubes were incubated at 37 °C with gentle 
agitation. At each predetermined time point i.e. after 1, 2, 6, 24, 48, 96, and 168 hours, 
all supernatants were collected for further analysis and the tubes were refreshed 
with 10 mL PBS. The concentration of lidocaine was detected by reverse-phase high-
performance liquid chromatography (HPLC) according to a previously reported 
method [24]. The HPLC system consisted of a L-2130 pump (Hitachi, Tokyo, Japan), a 
L-2400 UV detector (Hitachi), a L-2200 autosampler (Hitachi), and a LiChrospher RP-
18 endcapped HPLC column (125 mm × 4 mm, particle size 5 µm, Sigma-Aldrich). For 
lidocaine detection, the used mobile phase was acetonitrile: ammonium acetate 
(0.0257 M), pH 4.85 (adjusted with acetic acid) in the ratio of 60/40 (v/v). The injection 
volume was 20 µL with a flow rate of 0.5 mL/min. The concentration of lidocaine was 
quantified at 254 nm using a standard calibration curve in the concentration range 
between 4 and 1000 µg/mL. The silver concentration in the collected supernatants 
was determined by atomic absorbance spectroscopy (AAS, SpectrAA 220FS, Varian, 
Palo Alto, CA). The collected supernatant was acidified using 65% nitric acid (Aladdin, 
Shanghai, China) to a 1% nitric acid solution before AAS analysis. A standard calibration 
curve was prepared with silver concentrations ranging from 8 to 1000 ng/mL. 
2.5 Antibacterial property
Disk samples (n = 3 for each type) were immersed in 1.5 mL of PBS with gentle agitation 
at 37°C. The supernatants were collected daily for 7 days and stored respectively. 
Then 1.5 mL fresh PBS was added. Filter papers, 6-mm in diameter, were immersed 
into the collected supernatants for 30 seconds and  subsequently air dried for further 
use. A zone of inhibition test (modified Kirby–Bauer test) was adopted to evaluate the 
antibacterial property of the filter papers against Staphylococcus aureus (S. aureus 
ATCC® 25923™, Manassas, VG) and Escherichia coli (ATCC® 25922™). Standard 
tablets containing 30 µg of cefoxitin were used as positive control. In brief, a bacterial 
suspension was prepared by mixing bacterial colonies with sterile saline (0.85% w/v 
NaCl in water) to an OD value of 0.090 and further diluted for 10 times. The bacterial 
suspension was smeared evenly on nutrient agar plates (Jiangmen Caring Trading 
Company Limited, Jiangmen, China). Subsequently, three filter papers from different 
disk samples were distributed on each agar plate. After incubation for 20 hours at 
36°C, the diameters of the transparent zones of inhibition (ZOI) were measured. 
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2.6 Cytotoxicity
The cytotoxicity of the membranes was evaluated by the Cell Counting Kit-8 (CCK-8) 
assay [25]. All experiments were done by following national guidelines for working with 
human materials (Dutch Federation of Biomedical Scientific Societies, human tissue 
and medical research: code of conduct for responsible use. Available at http://www.
federa.org/). Before the evaluation, disk samples from each group (n = 3) were pre-
immersed in 1.5 mL culture medium at 37 °C for 24 hours with gentle agitation to 
collect the supernatants. Human Foreskin Fibroblasts (HFFs, isolated from foreskin 
specimens from a healthy donor by following national guidelines for working with 
human materials) and MC3T3-E1 osteoblastic cells (ATCC) were cultured in αMEM cell 
culture medium (Gibco®) supplemented with 10% Fetal Bovine Serum (FBS, Sigma 
F7524, Taukirchen, Germany) and 1% Penicillin/ Streptomycin (Gibco®) under a 5% CO2 
atmosphere at 37 °C. The cells were seeded onto a 24-well plate with a cell density of 
20 000 cells per well. After 24 hours, the culture medium in the plate wells was replaced 
with the collected supernatants or 5% DMSO groups (positive control) to start the 
evaluation. Again, 20 hours later, the culture medium was refreshed with 1 mL culture 
medium containing 10 v/v% CCK-8 dye to measure the metabolic activity of the cells. 
After 2 hours of incubation, a 100 µl aliquot of the metabolized medium from each well 
was transferred into a 96-well plate in duplicate and the absorbance was measured at 
450 nm in a Synergy HTX multimode reader (BioTek Instruments, Winooski, VT, USA).
2.7 Statistics
All data were reported as mean ± standard deviation (SD). The data were analyzed by 
a two-way ANOVA followed by a Tukey’s multiple comparisons test using GraphPad 
Prism 5.0 (GraphPad Software Inc., San Diego, CA). Furthermore, an independent 
t-test was performed to compare the cytotoxicity of drug-loaded groups to negative 
controls. Differences were considered as statistically significant at p < 0.05.
3 Results and Discussion
3.1 The fabrication of the scaffolds
To illustrate the pneumatic extrusion-based 3D printing, a cylindrical plate provided 
with a pillar was designed and printed (Figure 1). All scaffolds, as used in the various 
assays, could be without any problems printed using a 0.21 or 0.41 mm-diameter 
nozzle at a speed of 4 mm/s and a constant pneumatic pressure of 450 kPa under 
ambient conditions. 
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3.2 Morphology of the scaffolds
 
 Figure 2 |  The structure of 3D printed scaffolds. (A) 0.21 scaffold, (B) 0.41 scaffold. Scale 
bar: 1 mm.
Figure 2 shows the 3D structure of the scaffolds after micro-CT reconstruction. The 
scaffolds displayed a porous interconnected structure formed by microfilaments. 
The scaffolds prepared with the 0.21 or 0.41 mm nozzle could easily be discerned 
from each other on basis of the filament diameter (Figure 2). Further quantification 
of micro-CT data demonstrated that the surface area-to-volume ratios of the scaffolds 
from 0.21 and 0.41 groups were identical, both around 0.15 /pixel. Since drug release 
is primarily driven by diffusion, the comparable surface areas of the scaffolds formed 
a sturdy basis for the further comparison on the effect of the filament diameter. The 
quantification of the filament diameter from SEM images (Table 2) confirmed that: (1) 
filament diameter of the 0.21 and 0.41 scaffold group was indeed different, i.e. ~ 73 µm 
and 144 µm, and (2) no significant differences existed in filament diameter among the 
different drug loaded groups printed with the nozzle of the same size. The observed 
discrepancy between filament diameter and the internal diameter of the nozzles may 
be due to the fluidal characteristics of the dissolved polymer. As soon as the polymer 
slurry leaves the tip of the nozzle, it will flow to a wider diameter till the solvent is 
completely vaporized and the polymer is stabilized again. This flow can even become 
increased by the constant pneumatic pressure in the delivery of the slurry.
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Table 2 | The filament diameters of scaffolds from different groups.
 0.21 0.41
Drug0 72.2 ± 6.8 µm 136.3 ± 13.2 µm
L2 74.5 ± 7.1 µm 133.2 ± 16.5 µm
L4 72.7 ± 8.3 µm 146.0 ± 16.7 µm
Ag1 73.6 ± 6.5 µm 150.6 ± 17.8 µm
Ag3 74.0 ± 6.1 µm 152.9 ± 17.7 µm
Ag3L4 72.8 ± 7.2 µm 143.8 ± 14.6 µm
 
 
Figure 3 |  The morphology of the scaffold and the elemental distribution of lidocaine and 
Ag
3
PO
4
. The nitrogen was mapped in green to represent the lidocaine and the 
silver was mapped in red to represent Ag
3
PO
4
. Scale bar: 250 µm.
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The distribution of the lidocaine and Ag
3
PO
4
 throughout the filaments was analyzed 
by SEM-EDX, which confirmed that filaments contained silver (in red) and nitrogen (in 
green, indication of lidocaine). Elemental mapping demonstrated an even, spot-like 
distribution of the silver and lidocaine over the filaments (Figure 3). The cross-section 
of the scaffolds (Figure 4) showed that Ag
3
PO
4
, confirmed by EDX, embedded in PCL as 
microparticles, which still existed after 7-day immersion in PBS. No lidocaine particles 
were found in the lidocaine groups (Figure 4B), indicating that lidocaine was dissolved 
by the organic solvent and dispersed in the filaments.
  
Figure 4 |  The cross-section of filament from (A) Drug0 group, (B) L4 group,(C) Ag3 group, 
and (D) Ag3 group after 7-day immersion in PBS. (E)  The energy dispersive 
spectrum from # area in C. Scale bar: 10 µm.
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3.3 The drug release profiles
Figure 5A&B shows the release profile of the lidocaine from the various scaffolds. 
When the scaffolds were loaded only with lidocaine, the majority of the lidocaine was 
released in 6 hours and 24 hours from 0.21 groups (0.21L2 and 0.21L4) and 0.41 groups 
(0.41L2 and 0.41L4), respectively. These results corroborate with the principles of 
diffusion-driven drug release. A decrease in filament diameter reduces the diffusion 
distance of the drugs. Notably, the dual loading of lidocaine and Ag
3
PO
4
 resulted in 
a delayed release of lidocaine at 48 and 96 hours for the 0.21Ag3L4 group and the 
0.41Ag3L4 group, respectively. Since the postoperative pain is greatest during the 
first 24-48 hours and will decrease with time [15] and the lidocaine-loaded scaffolds 
displayed a controlled release of lidocaine within 4-7 days, these scaffolds may well 
be a candidate to control postoperative pain. As the diameter of the nozzles, used in 
this study, did have the most commonly used nozzle diameters, i.e. 0.2 to 0.4 mm, 
for pneumatic extrusion [26], it is possible to further control and optimize the lidocaine 
release by using larger custom-made nozzles. Such larger tip diameters may also be 
beneficial to deliver other bioactive compounds for biomedical applications. 
The silver release profiles are displayed in Figure 5C&D. Generally, the silver showed 
a sustained release pattern for all silver-loaded groups. The sustained silver release 
profiles indicate that the Ag
3
PO
4
 loaded scaffolds can work as a depot to release silver 
ions in a long-term, i.e. at least 7 days, which may be paramount to exert long-term 
antibacterial functions. Comparing the 0.21 with 0.41 groups, i.e. 0.21Ag1 vs 0.41Ag1 
and 0.21Ag3 vs 0.41Ag3, no significant difference was found. This suggests that 
filament diameter did not play a key role in the silver release. Instead, comparison of 
the scaffolds with different Ag
3
PO
4
 amounts, the Ag1 groups (0.21Ag1 and 0.41Ag1) 
showed a significantly faster release rate than the Ag3 groups (0.21Ag3 and 0.41Ag3) 
but fewer silver amounts were released from the Ag1 groups than from Ag3 groups. 
Moreover, the Ag3 groups (0.21Ag3 and 0.41Ag3) showed a similar release profile 
with Ag3L4 groups (0.21Ag3L4 and 0.41Ag3L4). This result indicates that the further 
incorporation of lidocaine did not affect the silver release. Therefore, the data indicate 
that the silver release is correlated with the initial amount of Ag
3
PO
4
 as loaded in the 
scaffolds instead of the filament diameter. This discrepancy between lidocaine and 
silver release may be attributed to the different status of the drugs in the filaments, i.e. 
lidocaine was dispersed as molecules while Ag
3
PO
4
 was embedded as microparticles 
in the filaments (Figure 4). When the scaffolds were immersed in the release medium, 
lidocaine molecules are ready to be spread out, but the release was limited by the 
diffusion distance, which is related to the filament diameter. In contrast, the silver 
ions need to be firstly dissolved from Ag
3
PO
4
 particles and then diffused out of the 
filaments. The dissolution of silver ions from the Ag
3
PO
4
 particles is slow [13] and thus 
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dominated the silver release. As such, the silver release was mainly correlated with the 
Ag
3
PO
4
 loading amount instead of the filament diameter.
In this study, PBS was used as the release medium considering that PBS is the most 
simple and common medium for the release kinetics studies. However, the scaffolds 
will be subjected to completely different conditions when implanted into the body 
tissues, where the released drug is continuously diluted and undergoes protein 
binding. As a consequence, different drug release behavior and performance can occur 
under in vivo conditions  than observed in the in vitro release studies [27]. Therefore, 
despite the promising drug release profiles, data must be interpreted with care and in 
vivo studies are necessary to confirm the obtained data and prove the clinical potential 
of the designed scaffolds.
 
Figure 5 | The drug release profiles of the lidocaine (A&B) and silver (C&D).
3.4 The antibacterial efficacy
S. aureus and E. coli are two representatives of common gram-positive and gram-
negative bacteria in infected wounds. The results of the zone of inhibition test against 
these two bacteria are shown in Figure 6. Only the samples containing silver showed 
a transparent ZOI (Figure 6A). The ZOI against S. aureus was larger than against E. 
coli, which indicates that silver has a stronger effect against gram-positive bacteria 
than gram-negative bacteria (Figure 6B&C). This is confirmed by Taglietti et al., who 
reported that the extra thick peptidoglycan layer of the cell wall in the gram-positive 
bacteria prevents the penetration of silver [28]. No significant differences in antibacterial 
effect were found between the silver-loaded groups (Figure 6B&C). In addition, the 
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comparable antibacterial efficacy of Ag3 and Ag3L4 groups (Figure 6B&C) indicates 
that the loading of lidocaine did not affect the antibacterial efficacy of the silver-
loaded scaffolds. Furthermore, the release media of Ag1 and Ag3 groups were further 
evaluated to 7 days (Figure 6D&E). No significant difference was found between 0.21 
and 0.41 groups. As expected, the Ag3 groups showed a larger zone of inhibition than 
Ag1 groups. At day 7, the released medium from Ag1 groups lost its antibacterial efficacy, 
while the Ag3 groups remained effective. Evidently, the silver-loaded scaffolds proved 
that the clearance of organisms from infected tissues usually requires the sustained 
release of effective antibacterial drugs for  3 to 4 days [14]. Therefore, under the current 
experimental conditions, the antibacterial properties of the silver-loaded scaffolds seem 
suitable to prevent infections.
 
Figure 6 |  The antibacterial results. (A) the macroscopic images of zone of inhibition of the 
released media collected at day 1. The diameter of the samples is 6 mm. (B&D) 
showed the ZOI against S. aureus, while  (C&E) showed that against E. coli.
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3.5 The cytotoxicity of the scaffolds
Since higher concentrations of silver can induce cytotoxicity [12], cytotoxicity of the 
samples was further tested. The cytotoxicity of the scaffolds was evaluated by the 
CCK-8 assay to evaluate the metabolic activity of HFFs and MC3T3 cells. Drug0 and 
5% DMSO groups were set as negative and positive control, respectively. The results 
are shown in Figure 7. The 5% DMSO group resulted in a significant lower OD value 
for both cell types than the Drug0 group, which validated the test. No significant 
difference in cytotoxicity was found between 0.21 and 0.41 groups. Regarding the drug 
loading amounts, the lidocaine- or silver-loaded groups did not separately show any 
significant difference in cytotoxicity compared to the negative control, which indicates 
that the released lidocaine and silver ions after 24-hour immersion did not reach the 
toxic threshold to HFFs as well as MC3T3 cells. The therapeutic threshold of lidocaine 
is around 1.5 – 6.0 µg/mL [29,30]. Based on the release study, the released lidocaine 
from the L4 group was estimated to be around 800 µg/mL, which is far higher than the 
therapeutic threshold and thus implies the potential to control pain. In contrast, the 
Ag3L4 groups had a significant cytotoxic effect on the MC3T3 cells but not on HFFs. 
We hypothesize that this cytotoxic effect of Ag3L4 scaffolds to MC3T3 cells is because 
the released lidocaine and silver ions can increase the osmotic pressure of the culture 
medium and the accumulation of lidocaine and silver ions from Ag3L4 groups reached 
a tolerant hypertonic threshold to MC3T3 cells, but not to HFFs. This hypertonic 
condition is unlikely to happen in vivo due to the continuous flow and circulation of 
body fluids. Therefore, in vivo studies can now be designed to further elucidate the 
appropriate doses to achieve an appropriate antibacterial effect to prevent infections 
as well as analgesic efficacy to control the postoperative pain. 
 
Figure 7 |  The cell viability test of the scaffolds. (A) The results of human foreskin fibroblast. 
(B) The results of MC3T3 E1 clone 4 cell line. ** indicates P < 0.01 and *** indicates 
P < 0.001 compared to Drug0.
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4 Conclusion
The technological breakthrough of computer and information technology facilitates 
the fabrication of custom-made products based on computer-assisted design. Ag
3
PO
4
 
and lidocaine loaded PCL scaffolds were printed using a pneumatic extrusion-based 
3D printing. The scaffolds showed a porous structure with high fidelity. The delivery 
of lidocaine could be controlled by adjusting the filament diameter while that of 
silver release is correlated to the Ag
3
PO
4
 loading amount. The lidocaine was release 
in a controlled manner during 4-7 days and resulted in a concentration far above the 
therapeutic level of lidocaine. Moreover, the Ag
3
PO
4
 incorporation showed a sustained 
silver release profile and enhanced the antibacterial properties of the scaffolds for at 
least 6 days. Although the Ag3L4 scaffolds showed a toxic effect to MC3T3 cells, which 
can be due to the hypertonic effects of the dual-released lidocaine and silver, the 
lidocaine or Ag
3
PO
4
 loaded scaffolds alone did not evoke cytotoxicity to human foreskin 
fibroblasts and MC3T3 cells. Therefore, pneumatic extrusion-based 3D printing can 
provide a practical way to fabricate drugs loaded scaffolds. In vivo explorations can 
now be performed to validate the clinical efficacy and safety of the scaffolds.
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1 Summary
The application of biomaterials in the medical field has contributed to the development 
of medical devices that can support the functional loss of organs and improve the 
quality-of-life of the patients. However, biomaterials also attract microorganisms and 
produce niches for infection, which may eventually lead to the failure of the device. To 
combat biomaterials-associated infections, antibacterial agents can be incorporated 
into biomaterials to enhance their antibacterial properties. Silver, as a common 
antibacterial agent, has attracted research interest due to its superior antibacterial 
property and little tendency to induce resistance. To date, only several studies are 
available that evaluate the antibacterial efficacy of silver incorporated biomaterials in 
vivo. Besides, to evaluate the antibacterial efficacy of biomaterials, valid and reliable 
experimental animal infection models have to be available for the dedicated testing of 
medical devices. To this end, this thesis aimed to explore the efficacy in the use of silver 
to enhance the antibacterial property of polymeric biomaterials for several biomedical 
applications including wound dressing, percutaneous pin, guided tissue engineering 
membranes, and scaffolds for repairing critical-sized bone defects. Chapter 1 provides 
a general introduction of biomaterials-associated infections and the current status of 
research in the use of silver to enhance the antibacterial properties of biomaterials. 
This summary briefly describes the main findings of the research questions that were 
addressed in this thesis.
1  Which animal models in literature are available to evaluate the antibacterial 
properties related to percutaneous devices?
A reliable animal model is a prerequisite for the further evaluation of biomaterials. 
Percutaneous devices are among the most complicated infection situations in the 
clinic. Chapter 1 focuses on the construction of animal models for percutaneous 
device-related infections, and specifically the role of inoculation of bacteria in such 
models. Infections around percutaneous devices, such as catheters, dental implants, 
and limb prostheses, are a recurrent and persistent clinical problem. To promote the 
research on this clinical problem, the establishment of a reliable and validated animal 
model would be of keen interest. In this review, literature related to percutaneous 
devices was evaluated, and special attention was paid to studies involving the use 
of bacteria. The design of percutaneous devices, the susceptibility of various animal 
species, bacteria strains, amounts of bacteria, and method of inoculation, as well as 
the methods for subsequent evaluation of the infection, are discussed in detail. Given 
that an ideal animal model for percutaneous device related infection study is still not 
existent, this article presents the basis for the construction of such a standardized 
animal model for percutaneous device-related infection studies. The inoculation of 
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bacteria is critical to obtain an animal model for standardized studies for percutaneous 
device-related infections.
2  Do silver incorporated membranes hold potential for application in guided tissue/ 
bone regeneration?
The incorporation of silver nanoparticles into biomaterials is not an easy task and 
whether the incorporated silver nanoparticles can enhance the antibacterial property 
without compromising the biocompatibility of the biomaterial is questionable. Chapter 
3 aimed to evaluate the antibacterial potential and biological performance of silver 
nanoparticles in chitosan-based membranes. Electrospun chitosan/poly (ethylene 
oxide) membranes with different amounts of silver nanoparticles were evaluated for 
antibacterial properties and cytotoxicity in vitro and for tissue response in a rabbit 
subcutaneous model. The nanoparticles displayed dose-dependent antibacterial 
properties against Porphyromonas gingivalis and Fusobacterium nucleatum, 
without showing noticeable cytotoxicity. The membranes with silver nanoparticles 
evoked a similar inflammatory response compared to the membranes without silver 
nanoparticles. The antibacterial effect, combined with the findings on cyto- and 
biocompatibility warrants further investigation to the usefulness of chitosan/ poly 
(ethylene oxide) membranes with silver nanoparticles, for clinical applications like 
guided tissue regeneration.
3  Possess silver incorporated membranes antibacterial properties and wound 
healing ability when used as wound dressing?
Silver nanoparticles are widely explored to enhance the antibacterial properties of 
medical devices, such as wound dressings. However, no consensus has been reached 
on the efficacy and safety of silver nanoparticle incorporation. Chapter 4 aimed (1) 
to elucidate the effect of proteins and inorganic ions on the antibacterial properties, 
(2) to confirm the antibacterial efficacy in vivo, and (3) to evaluate the wound healing 
ability of silver nanoparticles incorporation into chitosan-based membranes. Three 
membranes with different amounts of silver nanoparticles were prepared. The 
antibacterial properties and silver release profile were evaluated after interacting with 
phosphate buffered saline or with serum in vitro. The antibacterial efficacy and the 
wound healing ability was explored in rats. The results indicated that the biological 
environment had strong influences on the silver release: the inorganic ions resulted 
in a slow release whereas the proteins formed a barrier to block the silver release. 
Consequently, a high amount of silver nanoparticles incorporation was necessary to 
achieve in vivo antibacterial effects. Moreover, the addition of silver nanoparticles did 
not alter the wound healing rate and tissue response. We can conclude that the silver 
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nanoparticle incorporation can enhance the antibacterial efficacy of biomaterials 
while having good wound healing ability. Therefore, the silver incorporated chitosan-
based membranes are potential as antibacterial wound dressings.
4  Can silver nanoparticles incorporated in chitosan-based membranes effectively 
prevent infection as pin sleeves?
Various strategies have been explored to prevent pin tract infections (PTI), including 
the use of antibacterial sleeves. However, a validated and reliable animal model 
to evaluate the efficacy of antibacterial strategies is still lacking. Chapter 5 aimed 
to construct an animal model with a consistent induction of infection after bacterial 
challenge. Further, the efficacy of silver and chlorhexidine loaded chitosan sleeves 
was evaluated to prevent PTI around a percutaneous implant. Titanium pins 
wrapped with sleeves were implanted in the anterior lateral rabbit tibia. After two 
weeks, Staphylococcus aureus suspensions (1 × 106 CFU) were injected weekly 
to the exit site, and the clinical infection status was recorded. After six weeks, all 
rabbits were euthanized to evaluate the bacterial colonization microbiologically and 
histomorphometrically. Results showed that the implant screw bilaterally penetrated 
the tibia and kept the implant stable. A rod length of twice the thickness of the soft-
tissue layer was necessary to maintain the percutaneous penetration of the implants. 
A 100% infection rate was obtained by the bacterial inoculation. Silver loaded sleeves 
reduced significantly the bacterial density and reduced the inflammatory symptoms 
of the percutaneous pin tract. However, the addition of chlorhexidine to the sleeves 
had no added value in terms of further reduction of bacteria and inflammation. In 
conclusion, a consistent animal model was designed to evaluate strategies to prevent 
PTI. In addition, the use of silver loaded chitosan sleeves can be pursued for further 
(pre-)clinical exploration for the prevention of PTI.
5  Can silver and lidocaine be loaded into materials by 3D printing technique to 
prevent bacterial infection as well as provide pain relief (Chapter 6)? 
Pneumatic extrusion-based 3D printing can be used to fabricate custom-made 
scaffolds to restore irregular bone defects. During the 3D printing process, therapeutic 
agents can be added to the scaffolds. This study aimed to develop a polycaprolactone 
(PCL) scaffold loaded with Ag
3
PO
4
 to prevent infections and lidocaine for pain relief by 
one-step 3D printing. We hypothesized that the drug release could be controlled by 
varying the filament diameter of the 3D printed scaffolds. To this end, polycaprolactone 
(PCL) slurry mixed with different amounts of silver phosphate and lidocaine was 
printed via differently sized nozzles. The obtained cylindric scaffolds displayed a 
porous interconnected microstructure with high fidelity. The Ag
3
PO
4
 and lidocaine were 
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distributed homogeneously. The lidocaine release could be controlled by adjusting 
the filament diameter while the silver release is correlated with the Ag
3
PO
4
 loading 
amount. The released medium from silver-loaded scaffolds exhibited an obvious 
inhibition zone against Staphylococcus aureus and Escherichia coli upon loading with 
1% Ag
3
PO
4
 for up to 6 days and with 3% Ag
3
PO
4
 for at least 7 days. Cytotoxicity of all 
scaffolds was screened by cell assay. In conclusion, the pneumatic extrusion-based 3D 
printing provides a practical technique to fabricate drug-loaded scaffolds. The Ag
3
PO
4
 
and lidocaine loaded PCL scaffolds showed the potential for infection prevention and 
pain relief.
2 Closing remarks and future perspectives
This thesis explored the use of silver to enhance the antibacterial efficacy of polymeric 
biomaterials both in vitro and in vivo. The silver loaded polymers displayed a 
sustained release of silver ions and correspondingly exhibited prolonged antibacterial 
properties against anaerobic gram-positive and gram-negative bacteria (Chapter 3) as 
well as aerobic gram-positive and gram-negative bacteria (Chapter 4, 5, and 6). The 
silver loaded chitosan-based membranes did not evoke a stronger subcutaneous 
inflammatory response on compared to the membranes without silver (Chapter 3) 
and did not alter the cutaneous wound healing ability of skin wounds (Chapter 6). 
Nonetheless, since the design of medical devices is determined by their application 
site, the antibacterial efficacy of biomaterials has to be assessed for a specific 
application as well as situation in which the biomaterials are used [1]. Therefore, this 
thesis is an initial step towards the translation of the use of the silver to enhance the 
antibacterial effect of biomaterials for use in medical devices. More research has to 
be done to determine the final benefit of silver-based biomaterials and their human 
clinical application. 
When biomaterials are placed or in contact with tissues of the body, a number of 
reactions to the materials may be seen over time. Some of these reactions may 
constitute the determinants of the functionality of the biomaterials. Regarding the 
silver incorporated polymers, the biological environment had a strong influence 
on the silver release, i.e. the inorganic ions resulted in a slow release, whereas the 
deposited proteins as present in the body fluids formed a barrier to block the silver 
release. Consequently, a higher amount of silver nanoparticles incorporation was 
necessary to achieve in vivo antibacterial effects (Chapter 4). To date, reliable methods 
to assess the antibacterial efficacy of the incorporated silver, as the possible the effect 
of biological factors, like the various ions and proteins present in the body fluids, are 
still unknown. Since the composition of body fluids varies, the proper characterization 
and quantification of silver in relevant medium and in situ (inside cells/organisms) is 
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of paramount importance for final medical application [2]. Lack of such assessments 
probably explains (at least partially) the differences between experimental results in 
literature and difficulties in the interpretation of the obtained data. We propose that 
a proper relation between analytical techniques and biological studies needs to be 
established. For instance, a balanced system that is suitable for the growth of both 
bacteria and cells has to be constructed to evaluate the antibacterial efficacy as well as 
cell viability of the modified biomaterials in similar conditions.
A major task of translational medicine is the “effective translation of the new 
knowledge, mechanisms, and techniques generated by advances in basic science 
research into new approaches for prevention, diagnosis, and treatment of disease 
is essential for improving health” [3]. In this process, animal models serve as a 
surrogate for patients to evaluate the effectiveness and safety of novel diagnostic 
and therapeutic advances. Currently, animal models remain a unique source of in vivo 
information and the irreplaceable link between in vitro studies and final application 
in patients [4]. Regarding silver-related research, there is the drive to develop novel 
silver forms such as silver nanoparticles or silver-based materials, but much less 
research has been done on the in vivo evaluation of the effectiveness and safety of 
these newly developed materials. A reliable animal model is of great value to the 
evaluation of the effectiveness and safety of the biomaterials. Since no ideal infection 
model related to percutaneous devices was available, a review was conducted to 
figure out the paramount factors of such an animal model (Chapter 2). Subsequently, 
a valid and reliable rabbit model was constructed based on this review and the applied 
silver loaded sleeve seems suitable for further (pre-) clinical exploration (Chapter 4). 
Certainly, the validation of infection-resistant biomaterials for effective downstream 
translation can only be obtained in human clinical trials, and unfortunately, this is 
often where the development of an antimicrobial biomaterial terminates due to the 
large, costly, and lengthy requirements in clinical trials [5]. For instance, to lower the 
incidence rate of infections for total hip arthroplasties from 2% to 1%, around 5000 
patients are needed to demonstrate the 50% reduction of infection incidence based on 
a power calculation with P <0.05 [5]. Moreover, when medical devices intend to enter the 
U.S. market through a Food and Drug Administration (FDA) regulatory, these devices 
will be first classified into three classes according to the Medical Device Amendments 
of 1976 to the Federal Food, Drug, and Cosmetic Act (the act). Class I and II devices 
only need to undergo review for substantial equivalence to devices that are already 
on the market, also called pre-amendment devices. In contrast, Class III devices have 
to undergo a more rigorous premarket approval (PMA), the only pathway that requires 
clinical data [6]. In this thesis, we explored the effect of the incorporation of silver for 
GTR membranes, wound dressings, and pin sleeves. Since the membranes will not 
be implanted permanently, these applications will probably be classified as class II 
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devices. Regarding the class I and II devices, animal experiments can be the last 
validation step before human application. Therefore, the decisions on the choice of a 
relevant animal model and the design, execution, and evaluation of the experiments 
are of pivotal importance for the effectiveness and safety. When the animal models 
related to percutaneous devices were reviewed, the animal species, the strain of 
bacteria, amount and method of inoculation, and the methods for subsequent 
evaluation of the infection were quite variable, which makes it difficult to compare the 
different studies. If the animal models can be standardized, the results will be better 
comparable and more valuable information may be extracted through systematic 
reviews. Finally, this  will benefit the progress in the biomedical field.
Currently, silver has been applied as antibacterial agent in various forms such as silver 
compounds and silver nanoparticles [10]. The silver incorporated membranes displayed 
a dose-dependent antibacterial property and cytotoxicity (Chapter 3). Together with 
other studies [7,8], a therapeutic window, which can display antibacterial property 
without being toxic, is existing. While this therapeutic window provides a basis for 
the further exploration of the silver for biomedical applications, the risk of toxicity 
should not be neglected. The further exploration to control the delivery of silver by 
incorporating silver phosphate into polycaprolactone via 3D printing resulted in a 
controlled release of silver ions and sustained antibacterial effect for at least 6 days 
(Chapter 6). Therefore, the most advantageous property of silver agents, such as silver 
nanoparticles and silver phosphate particles, seems to be that the incorporated silver 
per se act as depots and show a sustained release of silver ions. To make full use of the 
silver, a precise control over the delivery of silver may be achieved through responsive 
controlled release techniques in the future. Varieties of drug release systems are 
constructed such as exogenously-triggered (thermo-responsive, light-responsive, 
and ultrasound-responsive), endogenously-triggered (redox-responsive, oxidation-
responsive, and pH-responsive), and enzyme-triggered drug release [9]. For instance, 
when the silver can be incorporated into an ultrasound-responsive release system, the 
sustained release of silver can be triggered by ultrasound exposure upon the existence 
of infection symptoms. Overall, the use of silver to enhance the antibacterial properties 
of the biomaterials are quite promising. By precisely controlling the delivery of silver, 
antibacterial biomaterials can be of excellent benefit to prevent the occurrence of 
infections associated with medical devices.
In summary, the use of silver to enhance the antibacterial properties of biomaterials 
has been shown a promising potential for the prevention of infections. Although 
only several applications, including cutaneous wound dressing, percutaneous pin 
sleeves, and subcutaneous membranes and scaffolds, were explored in this thesis, the 
performed studies have laid down a firm basis for the further exploration of the use of 
silver incorporated biomaterials for antibacterial application. 
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1 Samenvatting
Biomaterialen worden in de medische sector gebruikt voor allerlei toepassingen 
om verloren weefsels en organen te vervangen, en daarmee de kwaliteit van leven 
van patiënten te verbeteren. Biomaterialen kunnen echter ook micro-organismen 
aantrekken en een haard van infectie vormen, waardoor een medisch hulpmiddel 
uiteindelijk kan falen. Om infecties rond biomaterialen te bestrijden, kunnen 
antibacteriële stoffen worden toegevoegd. Zilver wordt daarvoor bijvoorbeeld 
algemeen gebruikt. Zilver staat in de aandacht dankzij superieure antibacteriële 
eigenschappen, en de zeer lage waarschijnlijkheid van het optreden van resistentie. 
Op dit moment zijn er echter niet veel in vivo studies beschikbaar die de antibacteriële 
werking van zilver toegevoegd aan biomaterialen evalueren. Om de antibacteriële 
werking te evalueren, is het bovendien belangrijk dat er valide en betrouwbare 
diermodellen komen die beschikbaar specifiek gericht zijn op het testen van medische 
hulpmiddelen. 
In dit proefschrift werd dan ook getracht  om de effectiviteit van het gebruik van zilver 
te bestuderen, als antibacteriële stof toegevoegd aan polymere biomaterialen, in 
diverse  toerpassingen; zoals wondbedekkers, percutane fixatie pinnen, membranen 
voor weefselgeleiding, en dragermaterialen voor het repareren van kritische bot 
defecten. Hoofdstuk 1 geeft een algemene inleiding over infecties die geassocieerd 
zijn met biomaterialen, en de huidige stand van onderzoek op het gebied van het 
gebruik van zilver als antibacterieel middel. Deze samenvatting behandelt vervolgens 
de belangrijkste uitkomsten van de onderzoeksvragen zoals die in het inleidende 
hoofdstuk gesteld werden voor dit proefschrift.
1  Welke diermodellen zijn er in de wetenschappelijke literatuur beschikbaar om de 
antibacteriële eigenschappen te evalueren rond percutane implantaten?
Een betrouwbaar diermodel is een voorwaarde om biomaterialen te kunnen evalueren. 
Percutane implantaten vormen daarbij de meest gecompliceerde infectueuze 
klinische situaties. Hoofdstuk 2 focusseert op het construeren van diermodellen voor 
infecties bij percutane implantaten, and specifiek op de rol die het inoculeren van 
bacteriën kan hebben in zulke modellen. Infecties rond percutane implantaten, zoals 
katheters, tandheelkundige implantaten, en ledemaatprothesen, vormen een continu 
en hardnekkig klinisch probleem. Het opzetten van betrouwbare en gevalideerde 
diermodellen is daarmee van groot belang. In dit overzichtsartikel, wordt de literatuur 
over percutane implantaten geëvalueerd, waarbij in het bijzonder aandacht werd 
gegeven aan studies die bacteriën gebruikten. Het ontwerp van de percutane 
implantaten, de vatbaarheid van verschillende species, de bacterie stammen, 
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de hoeveelheid bacteriën, en de inoculatie methode, zowel als de methode van 
uiteindelijke evaluatie van de infectie, worden allen in detail besproken. Gegeven dat 
een ideaal diermodel voor infecties gerelateerd aan percutane implantaten nog niet 
bestaat, geeft dit hoofdstuk de basis voor het opzetten van zo’n gestandaardiseerd 
diermodel. Het blijkt dat het inoculeren van bacteriën daarbij in elk geval van kritisch 
belang is.
2  Hebben membranen waarin zilver is opgenomen potentieel voor toepassingen in 
geleide weefsel / bot regeneratie
Het opnemen van zilver nanopartikels in biomaterialen is makkelijker gezegd dan 
gedaan, en het is nog maar de vraag of de zilver nanopartikels de antibacteriële 
eigenschappen kunnen verbeteren zonder dat daarbij de biocompatibiliteit in 
het geding komt. Hoofdstuk 3 beoogde om het antibacteriële potentieel en het 
biologische gedrag van zilver nanopartikels te evalueren in membranen, die waren 
gebaseerd op chitosan. Chitosan/ poly (ethyleen oxide) membranen, vervaardigd 
met elektrospinnen, en voorzien van verschillende hoeveelheden zilver nanopartikels 
werden beschouwd op antibacteriële eigenschappen en cytotoxiciteit in vitro, 
en op weefsel response in een subcutaan konijnenmodel. De resultaten voor de 
nanopartikels lieten zien dat de antibacteriële eigenschappen afhankelijk waren van 
de dosering, werkzaam waren tegen  Porphyromonas gingivalis en Fusobacterium 
nucleatum, en geen merkbare cytotoxiciteit vertoonden. De membranen met de 
zilver nanopartikels lieten een vergelijkbare ontstekingsreactie zien ten opzichte 
van membranen zonder zilver nanopartikels. In conclusie kan gezegd worden dat het 
antibacteriële effect, in combinatie met de bevindingen over cyto- en biocompatibiliteit 
zou moeten leiden tot verder onderzoek naar de bruikbaarheid van chitosan/ poly 
(ethyleen oxide) membranen met zilver nanopartikels, voor klinische toepassingen 
zoals geleide weefsel regeneratie.  
3  Beschikken membranen met zilver over antibacteriële eigenschappen en stimuleren 
zij wondgenezing bij toepassing als een wondbedekker?
Zilver nanopartikels worden algemeen gebruikt om de antibacteriele eigenschappen 
van medische hulpmiddelen te verbeteren, bijvoorbeeld bij wondbedekkers. Er is 
echter zeker geen consensus over de werkzaamheid en veiligheid van de opgenomen 
nanopartikels. Hoofdstuk 4 probeerde om (1) het effect te verduidelijken dat 
proteïnen en anorganische ionen hebben op de antibacteriële eigenschappen, 
(2) de antibacteriële werkzaamheid te bevestigen in een in vivo model,  en (3) de 
mogelijkheid tot wondheling rond de  chitosan membranen met zilver nanopartikels 
te bestuderen. Er werden drie membranen gemaakt, met verschillende hoeveelheden 
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zilver nanopartikels. De antibacteriële eigenschappen en het profiel warmee het zilver 
vrijkwam, werden in vitro geëvalueerd, tijdens interactie met een fosfaatgebufferde 
zoutoplossing of met serum. De antibacteriële werkzaamheid en de wondheling 
werden ook onderzocht in ratten. De resultaten lieten zien dat de biologische omgeving 
het vrijkomen van zilver sterk beïnvloedde: de anorganische ionen zorgden namelijk 
voor een langzaam afgifteprofiel; terwijl de proteïnen een barrière vormden, die het 
vrijkomen in zijn geheel blokkeerde. Dientengevolge is een hoge hoeveelheid zilver 
noodzakelijk om ook in vivo antibacteriële effecten te kunnen bewerkstelligen. Het 
toevoegen van zilver nanopartikels veranderde de wondgenezing of het weefselgedrag 
niet. Daaruit kon geconcludeerd worden dat het toevoegen van zilver nanopartikels 
de antibacteriële werking van biomaterialen kan bevorderen, terwijl er nog steeds 
een adequate wondheling plaatsvindt. Chitosan membranen met toegevoegde zilver 
nanopartikels hebben potentieel als antibacteriële wondbedekkers.  
4  Kunnen chitosan membranen met zilver nanopartikels infectie voorkomen, 
wanneer deze worden toegepast als een hoesje rond fixatie pinnen?
Voor het voorkomen van infectie rond fixatie pinnen (PTI) worden verschillende 
strategieën onderzocht, zoals het gebruik van antibacteriële hoesjes. Een gevalideerd 
betrouwbaar diermodel, om de werkzaamheid van antibacteriële methoden te 
onderzoeken, ontbreekt echter. Hoofdstuk 5 probeerde een diermodel te ontwikkelen, 
met een consistente vorming van infectie na het toevoegen van bacteriën. Vervolgens 
werd de werkzaamheid van chitosan hoesjes met zilver en chloorhexidine bestudeerd, 
om PTI rond een percutaan implantaat te voorkomen. Titanium pinnen, bedekt met 
hoesjes, werden anterior lateraal geïmplanteerd in konijnentibia. Vanaf 2 weken, 
werden Staphylococcus aureus suspensies (1 × 106 CFU) wekelijks geïnjecteerd op 
de percutane passage, en werd de klinische infectie status vastgelegd. Na 6 weken, 
werden de konijnen geofferd om de bacteriële kolonisatie microbiologisch en 
histomorfometrisch te evalueren. De resultaten lieten zien dat de implantaatschroeven 
de tibia bilateraal penetreerden en het  implantaat stabiel was. Om de percutane 
status te behouden moest het implantaat twee keer zo lang zijn, als de dikte van het 
zachte weefsel ter plekke. Door de inoculatie met bacteriën ontstond er in 100% van de 
gevallen een infectie. De hoesjes met zilver zorgden voor een significant verminderde 
dichtheid van bacteriën, en verlaagden de symptomen van de ontsteking rond de 
percutane pin. Het toevoegen van chloorhexidine aan de hoesjes had echter geen 
meerwaarde voor het verder terugdringen van bacteriën en ontsteking. In conclusie 
kan gezegd worden dat een consistent diermodel ontworpen is om strategieën gericht 
op PTI te testen. Daarnaast zouden chitosan hoesjes met zilver verder ontwikkeld 
moeten worden voor (pre-) klinische doeleinden ter voorkoming van PTI.
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5  Kunnen zilver en lidocaïne in materialen geladen worden met behulp van een 3D 
print techniek, om bacteriële infectie te voorkomen en tegelijkertijd pijnverlichting 
te bewerkstelligen? 
Een 3D techniek met pneumatische extrusie kan gebruikt worden om individuele 
dragermaterialen te produceren, waarmee onregelmatige botdefecten hersteld 
kunnen worden. Gedurende het proces van 3D printen, kunnen er ook therapeutica 
aan het dragermateriaal toegevoegd worden. Het doel van Hoofdstuk 6 was om door 
middel van een eenstaps 3D print proces een polycaprolacton (PCL) drager materiaal 
te maken, met Ag
3
PO
4
 om infecties te bestrijden en lidocaïne om pijn te bestrijden. 
De hypothese was dat het vrijkomen van deze medicijnen daarbij gecontroleerd kon 
worden door filament diameter van de 3D dragermaterialen te variëren. Voor dit doel 
werd een polycaprolacton (PCL) slurry gemengd met verschillende hoeveelheden 
zilverfosfaat en lidocaïne en geprint door mondstukjes van meerdere groottes. De 
zo verkregen cilindrische dragermaterialen lieten een zeer regelmatige poreuze 
en interconnectieve microstructuur zien. De Ag
3
PO
4
 en lidocaïne waren homogeen 
gedistribueerd. Door het aanpassen van de filament diameter, kon inderdaad de 
vrijgave van lidocaïne en zilver gecontroleerd worden. Het medium met daarin het 
vrijgekomen zilver, liet een duidelijke zone van inhibitie zien tegen Staphylococcus 
aureus en Escherichia coli, na het laden met 1% Ag
3
PO
4
 voor een periode van 6 dagen 
en met 3% Ag
3
PO
4
 voor een periode van tenminste 7 dagen. De cytotoxiciteit van alle 
dragermateriaal werd tenslotte nog beschreven met een celkweek proef. In conclusie 
kon gezegd worden dat 3D printen met pneumatische extrusie een praktische techniek 
is om dragermaterialen te produceren met daarin medicijnen. De PCL dragers geladen 
met Ag
3
PO
4
 en lidocaïne hebben potentieel ter bestrijding van infectie en pijn.
2 Afsluitende opmerkingen en toekomstperspectief
Deze thesis onderzocht het gebruik van zilver, om de antibacteriële werking van 
polymere biomaterialen te verbeteren, in zowel in vitro als in vivo modellen. De 
polymeren die met zilver geladen waren, vertoonden een langdurige vrijgave van 
zilver ionen, en waren daarmee langdurig antibacterieel werkzaam tegen anaerobe 
gram-positieve en gram-negatieve bacteriën (Hoofdstuk 3), zowel als tegen aerobe 
gram-positieve en gram-negatieve bacteriën (Hoofdstuk 4, 5, en 6). De chitosan 
membranen met zilver lieten geen sterkere subcutane ontstekingsreactie zien 
vergeleken met membranen zonder zilver (Hoofdstuk 3) en zorgden niet voor 
veranderingen in de helingscapaciteit van huidwonden (Hoofdstuk 6). Aangezien het 
ontwerp van medische hulpmiddelen grotendeels bepaald wordt door de toepassing, 
moet de antibacteriële werking echter altijd getest worden voor die ene specifieke 
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toepassing, en voor de locale situatie [1]. Dit proefschrift is dus alleen een  initiële stap 
naar de translatie van het gebruik van zilver, en meer onderzoek zal nodig zijn om de 
uiteindelijke bijdrage van op zilver gebaseerde biomaterialen hard te maken in een 
humane klinische toepassing. 
Wanneer biomaterialen in het lichaam worden geplaatst of in contact zijn met 
weefsels, dan kunnen een diverse reacties waargenomen worden. Een aantal van 
deze reacties is bepalend voor de functionaliteit van de biomaterialen. Ten aanzien 
van de polymeren met zilver, had de biologische omgeving een sterke invloed op het 
vrijkomen van het zilver, d.w.z. anorganische ionen resulteerden in een langzame 
vrijgave, terwijl eiwitten afkomstig uit lichaamsvloeistoffen afgezet werden en een 
barrière vormden die zilver afgifte verhinderde. Dientengevolge was er een hogere 
hoeveelheid zilver nanopartikels nodig om in vivo nog steeds antibacteriële effecten 
te bewerkstelligen (Hoofdstuk 4). Op dit moment zijn er nog geen betrouwbare 
methoden om het antibacteriële effect van zilver te bepalen, aangezien het 
mogelijke effect van biologische factoren, zoals de verschillende ionen en eiwitten 
aanwezig in lichaamsvloeistof, nog onbekend zijn. Aangezien de samenstelling van 
lichaamsvloeistof veranderlijk is, is de exacte karakterisatie en kwantificatie van 
zilver in relevante media en in situ (in cellen/organismen) uiterst belangrijk voor de 
uiteindelijke medische toepassing [2]. Het gebrek aan zulke bepalingen verklaart 
waarschijnlijk (tenminste gedeeltelijk) de verschillen tussen experimentele resultaten 
in de literatuur, en de problemen in de interpretatie van verkregen data. We stellen dan 
ook voor, dat een goede relatie tussen analytische technieken en biologische studies 
noodzakelijk is. Er zou bijvoorbeeld een gebalanceerd systeem gemaakt moeten 
worden dat geschikt is om tegelijkertijd bacteriën en cellen te kweken, om hierin zowel 
antibacteriële werking als de levensvatbaarheid van cellen onder gelijke condities 
simultaan te kunnen meten.
Een belangrijke taak van translationele geneeskunde is het “effectief vertalen van 
nieuwe kennis, mechanismen, en technieken uit voortschrijdend fundamenteel 
onderzoek, tot nieuwe aanpakken voor de preventie, diagnose, en behandeling van 
ziekten” [3]. In dit proces dienen diermodellen als een surrogaat voor patiënten om 
de effectiviteit en veiligheid van nieuwe diagnostische en therapeutische aanpakken 
te kunnen testen. Op dit moment blijven diermodellen nog steeds een unieke bron 
van in vivo informatie en vormen zij een onvervangbare brug tussen in vitro studies 
en de uiteindelijke toepassingen in patiënten [4]. Op het gebied van zilver onderzoek 
worden er continue nieuwe vormen van zilver ontwikkeld, zoals zilver nanopartikels 
of materialen gebaseerd op zilver. Maar er is veel minder onderzoek naar de in vivo 
evaluatie van de effectiviteit en veiligheid van deze nieuw ontwikkelde materialen. 
Een betrouwbaar diermodel zou van grote waarde zijn om biomaterialen te kunnen 
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evalueren op basis van effectiviteit en veiligheid. Omdat een dergelijk ideaal model 
voor een infectie rond percutane implantaten nog niet bestond, is er eerst een 
literatuurstudie uitgevoerd om te kijken wat de belangrijkste factoren in een dergelijk 
model dienden te zijn (Hoofdstuk 2). Vervolgens werd een valide en betrouwbaar 
model opgezet in het konijn, op basis van deze literatuurstudie. De hoesjes geladen 
met zilver, die in het model werden beschouwd, bleken geschikt voor verdere 
(pre-) klinische studies (Hoofdstuk 4). De eigenlijke validatie van biomaterialen die 
resistent zijn tegen infectie kan natuurlijk alleen gedaan worden in humane klinische 
experimenten. Helaas is dit echter het moment waarop de ontwikkeling vaak stopt, 
gezien de grootte, de kosten, en de lange tijd die klinische experimenten vereisen 
[5]. Om bijvoorbeeld de  incidentie van infecties voor totale heup arthroplastie te 
verlagen van 2% naar 1%, zijn ongeveer 5000 patiënten nodig wanneer een 50% 
reductie aangetoond moet worden, gebaseerd op een statistische power calculatie 
met p <0.05 [5]. Wanneer een medisch hulpmiddel bestemd is voor de Amerikaanse 
markt, dan zal de Food and Drug Administration (FDA) zulke hulpmiddelen eerst 
klassificeren volgens de Medical Device Amendments of 1976 to the Federal Food, 
Drug, and Cosmetic Act. Klasse I en II hulpmiddelen moeten beschouwd worden op 
substantiële vergelijkbaarheid met hulpmiddelen die reeds toegelaten zijn, dit noemt 
men pre-amendment devices. In tegenstelling, moeten Klasse III hulpmiddelen 
door de stringente procedure van premarket approval (PMA), en deze route vereist 
ook klinische data [6]. In dit proefschrift werd het effect van de toevoeging van zilver 
voor GTR membranen, wondbedekkers, en hoesjes rond fixatie pinnen beschouwd. 
Aangezien membranen niet permanent geïmplanteerd worden, zal een dergelijke 
toepassing waarschijnlijk beschouwd worden als klasse II. Voor klasse I en II 
toepassingen kunnen dierexperimenten de laatste validatie stap vormen, voorafgaand 
aan toepassing in de mens. Daarom zijn keuzes over een relevant diermodel en de 
opzet, uitvoering, en evaluatie van die experimenten van wezenlijk belang voor het 
aantonen van de werkzaamheid en veiligheid. Wanneer diermodellen over percutane 
hulpmiddelen besproken worden, zijn de species, de bacterie stam, de hoeveelheid 
en methode van inoculatie, en de methode voor uiteindelijke evaluatie van de 
infectie steeds erg variabel, wat het onderling vergelijken van studies compliceert. 
Als diermodellen gestandaardiseerd kunnen worden, zijn resultaten onderling beter 
vergelijkbaar en kan veel waardevollere informatie gewonnen worden in systematisch 
literatuuronderzoek. Dit zal uiteindelijk ook meer vooruitgang opleveren op het 
medisch vlak.
Op dit moment wordt zilver in vele vormen toegepast als antibacterieel middel, zoals 
in zilversamenstellingen en zilver nanopartikels [10]. Het zilver wat opgenomen was in 
membranen liet een antibacteriële werking en cytotoxiciteit zien die afhankelijk was 
van de dosering (Hoofdstuk 3). Samen met andere studies [7,8], kan gezegd worden 
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dat er dus een therapeutische dosering moet bestaan die antibacterieel is, zonder 
tegelijkertijd toxisch te zijn. Dit schept een basis voor verder onderzoek naar zilver 
voor biomedische toepassingen, maar het risico op toxiciteit kan natuurlijk nooit 
geheel buiten beschouwing gelaten worden. Verder onderzoek naar gecontroleerde 
afgifte van zilver, door de zilverfosfaat op te nemen in polycaprolacton via 3D 
printen resulteerde in een dergelijke gecontroleerde afgifte van zilverionen en een 
aanhoudend antibacterieel effect gedurende tenminste 6 dagen (Hoofdstuk 6). De 
meest gunstige eigenschap van zilver samenstellingen zoals zilver nanopartikels 
en zilverfosfaat partikels lijkt dus de depot werking met de geleidelijke afgifte van 
zilverionen. Het zou verder optimaal zijn om echt exacte controle over de afgifte te 
verkrijgen, wat wellicht zou kunnen door gebruik te maken van nieuwe technieken. 
Er bestaan verschillende van zulke vernieuwende afgifte systemen die van buitenaf 
gestuurd kunnen worden (op basis van temperatuur, licht, en ultrasoon geluid), van 
binnen uit het lichaam (redox-, zuurstof, of pH- afhankelijk), of door enzymatisch 
gestuurde medicijnafgifte [9]. Zilver kan bijvoorbeeld ingesloten worden en vervolgens, 
bij het optreden van symptomen van infectie, vrijgegeven worden met behulp van 
blootstelling aan ultrasoon geluid. Over het geheel genomen is het gebruik van zilver 
veelbelovend. Door het verder controleren van de afgifte van zilver kunnen wellicht 
biomaterialen gemaakt worden die zelfs infectie kunnen voorkomen.
In samenvatting kan gesteld worden dat het gebruik van zilver een belovende 
techniek is. Alhoewel slechts enkele toepassingen zijn onderzocht, te weten huid 
wond bedekkers, hoesjes voor percutane implantaten, en subcutane membranen 
en dragermaterialen, hebben deze studies toch een duidelijke basis gelegd voor 
verder onderzoek naar het gebruik van zilver om  antibacteriële eigenschappen voor 
biomaterialen te verkrijgen.  
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